<SEC-DOCUMENT>0000731766-21-000049.txt : 20211029
<SEC-HEADER>0000731766-21-000049.hdr.sgml : 20211029
<ACCEPTANCE-DATETIME>20211029165245
ACCESSION NUMBER:		0000731766-21-000049
CONFORMED SUBMISSION TYPE:	S-8
PUBLIC DOCUMENT COUNT:		6
FILED AS OF DATE:		20211029
DATE AS OF CHANGE:		20211029
EFFECTIVENESS DATE:		20211029

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UNITEDHEALTH GROUP INC
		CENTRAL INDEX KEY:			0000731766
		STANDARD INDUSTRIAL CLASSIFICATION:	HOSPITAL & MEDICAL SERVICE PLANS [6324]
		IRS NUMBER:				411321939
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-8
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-260606
		FILM NUMBER:		211363953

	BUSINESS ADDRESS:	
		STREET 1:		UNITEDHEALTH GROUP CENTER
		STREET 2:		9900 BREN ROAD EAST
		CITY:			MINNEAPOLIS
		STATE:			MN
		ZIP:			55343
		BUSINESS PHONE:		9529361300

	MAIL ADDRESS:	
		STREET 1:		9900 BREN ROAD EAST
		CITY:			MINNETONKA
		STATE:			MN
		ZIP:			55343

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	UNITED HEALTHCARE CORP/
		DATE OF NAME CHANGE:	20000309

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	UNITED HEALTHCARE CORP
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-8
<SEQUENCE>1
<FILENAME>s-8espp.htm
<DESCRIPTION>S-8
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i3f9dfcaf52544852a54ec842c06065af_33"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">As filed with the Securities and Exchange Commission on October 29, 2021</font></div><div style="text-align:justify;text-indent:288pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">     </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Registration Statement No. 333- </font></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.419%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.419%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.419%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.419%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.724%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:112%">UNITED STATES</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:112%">SECURITIES AND EXCHANGE COMMISSION</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:112%">Washington, D.C. 20549</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:112%">FORM S-8</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:112%">REGISTRATION STATEMENT</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%">UNDER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%">THE SECURITIES ACT OF 1933</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:24pt;font-weight:700;line-height:112%">UnitedHealth Group Incorporated</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">(Exact name of registrant as specified in its charter)</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:30.252%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.771%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.252%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.771%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.254%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Delaware</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:112%">41-1321939</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">(State or other jurisdiction of</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">incorporation or organization)</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">(I.R.S. Employer</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Identification No.)</font></div></td></tr></table></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">                                                                                 </font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.752%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.874%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.074%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:112%">UnitedHealth Group Center</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:112%">9900 Bren Road East</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Minnetonka, Minnesota</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:112%">55343</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">(Address of Principal Executive Offices)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">(Zip Code)</font></div></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%">UNITEDHEALTH GROUP 1993 EMPLOYEE STOCK PURCHASE PLAN</font></div></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">(Full title of the plan)</font></div></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Marianne D. Short</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Executive Vice President and Chief Legal Officer</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:112%">UnitedHealth Group Center</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:112%">9900 Bren Road East</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Minnetonka, Minnesota 55343</font></div></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">(Name and address of agent for service)</font></div></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:112%">(952) 936-1300</font></div></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">(Telephone number, including area code, of agent for service)</font></div></td></tr></table></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and emerging growth company in Rule 12b-2 of the Exchange Act. </font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.541%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.105%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.883%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.925%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.932%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.707%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.107%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify;text-indent:13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:110%">Large accelerated filer</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#9746;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:110%">Accelerated filer</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#9744;</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify;text-indent:13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:110%">Non-accelerated filer</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#9744;</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:110%">Smaller reporting company</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#9744;</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:110%">Emerging growth company</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#9744;</font></div></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:110%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:110%">&#9744;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:110%"> </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.725%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.598%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.503%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.663%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">CALCULATION OF REGISTRATION FEE</font></td></tr><tr><td colspan="3" style="border-top:3pt double #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Title of securities to be registered</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:3pt double #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Amount to be</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:112%">registered</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:700;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline">(1)</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:3pt double #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Proposed</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:112%">maximum offering</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:112%">price per share</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:700;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline">(2)</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:3pt double #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Proposed maximum aggregate offering price</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:700;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline">(2)</font></div></td><td colspan="3" style="border-left:1pt solid #000;border-top:3pt double #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Amount of registration fee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:700;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline">(2)</font></div></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Common Stock ($.01 par value per share</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">).............</font></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">15,000,000</font></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$452.65</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$6,789,750,000</font></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$629,409.83</font></td></tr></table></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%;padding-left:7.52pt">Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), this registration statement covers, in addition to the number of shares of common stock, par value $.01 per share (the &#8220;Common Stock&#8221;), of the registrant shown in the table, an indeterminate number of shares which may become issuable under the UnitedHealth Group 1993 Employee Stock Purchase Plan by reason of any stock dividend, stock split, recapitalization or other similar transaction effected without receipt of consideration which results in an increase in the number of shares of Common Stock. </font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%;padding-left:7.52pt">Estimated in accordance with Rules 457(c) and Rule 457(h) under the Securities Act, solely for the purpose of calculating the amount of the registration fee, based on the average of the high and low sales prices per share of the Common Stock on October 26, 2021, as reported on the New York Stock Exchange.</font></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.419%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.419%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.419%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.419%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.724%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><div id="i3f9dfcaf52544852a54ec842c06065af_39"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">EXPLANATORY NOTE</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> </font></div><div style="margin-top:6pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">This registration statement is being filed to register an additional 15,000,000 shares of Common Stock made available for issuance under the UnitedHealth Group 1993 Employee Stock Purchase Plan (the &#8220;Plan&#8221;). In accordance with General Instruction E to Form S-8, this registration statement incorporates by reference the contents of Registration Statement No. 333-174437 on </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a href="http://www.sec.gov/Archives/edgar/data/731766/000119312511148561/ds8.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Form S-8</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> filed by UnitedHealth Group Incorporated (the &#8220;Company&#8221;) on May 24, 2011, Registration Statement No. 333-151569 on </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a href="http://www.sec.gov/Archives/edgar/data/731766/000119312508131261/ds8.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Form S-8</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> filed by the Company on June 10, 2008, Registration Statement No. 333-04875 on</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a href="http://www.sec.gov/Archives/edgar/data/731766/0000731766-96-000008.txt" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"> Form S-8</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> filed by the Company on May 31, 1996 and Registration Statement No. 33-68158 on Form S-8 filed by the Company on August 27, 1993 relating to shares of Common Stock issuable pursuant to the Plan. The increase in the number of shares authorized for issuance under the Plan was approved by the Company&#8217;s stockholders at its 2021 annual meeting held on June 7, 2021.</font></div><div style="margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">PART I.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">INFORMATION REQUIRED IN THE SECTION 10(a) PROSPECTUS</font></div><div><font><br></font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The documents containing the information specified in this Part I of Form S-8 will be sent or given to participants in the Plan as specified by Rule 428(b)(1) under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;). Such documents need not be filed with the Securities and Exchange Commission (the &#8220;SEC&#8221;) either as part of this registration statement or as prospectuses or prospectus supplements pursuant to Rule 424 under the Securities Act.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">These documents and the documents incorporated by reference pursuant to Item 3 of Part II of this registration statement, taken together, constitute a prospectus that meets the requirements of Section 10(a) of the Securities Act.</font></div><div style="margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">PART II.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">INFORMATION REQUIRED IN THE REGISTRATION STATEMENT</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Item 3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Incorporation of Documents by Reference.</font></div><div style="margin-top:6pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company incorporates by reference herein the following documents filed by it with the SEC under Commission File Number 1-10864 pursuant to the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), other than any portion of such documents or information therein deemed to have been furnished and not filed in accordance with SEC rules&#58;</font></div><div style="margin-bottom:8pt;margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:112%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:6.36pt">the Company&#8217;s Annual Report on </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/731766/000073176621000013/unh-20201231.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Form 10-K</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> for the fiscal year ended December 31, 2020 (including those portions of the Company&#8217;s Definitive Proxy Statement on </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a href="http://www.sec.gov/Archives/edgar/data/731766/000104746921001031/a2243195zdef14a.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Schedule 14A</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> filed with the SEC on April 26, 2021 that are incorporated by reference into Part III of such Annual Report on Form 10-K)&#59;</font></div><div style="margin-bottom:8pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">the Company&#8217;s Quarterly Reports on Form 10-Q for the quarterly periods ended </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/731766/000073176621000021/unh-20210331.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">March 31, 2021</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/731766/000073176621000037/unh-20210630.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">June 30, 2021</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#59;</font></div><div style="margin-bottom:10pt;margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.36pt">the Company&#8217;s Current Reports on Form 8-K filed with the SEC on </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/731766/000073176621000004/unh-20210202.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">February 8, 2021</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/731766/000073176621000010/unh-20210222.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">February 26, 2021</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/731766/000119312521166654/d146030d8k.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">May 19, 2021</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/731766/000073176621000028/unh-20210607.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">June 11, 2021</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#59; and </font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.77pt">the Description of the Company&#8217;s Common Stock set forth in Exhibit 4.5 to the Company&#8217;s Annual Report on </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="http://www.sec.gov/Archives/edgar/data/731766/000073176620000006/unhex4512312019.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Form 10-K</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for the fiscal year ended December 31, 2019, including any amendment or report filed for the purpose of updating such description.</font></div><div style="margin-bottom:6pt;margin-top:3pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In addition, the Company incorporates by reference all documents filed by it pursuant to Section 13(a), 13(c), 14 or 15(d) of the Exchange Act (other than, in each case, documents or information therein deemed to have been furnished and not filed in accordance with SEC rules, unless specifically incorporated by reference in this registration statement) subsequent to the date hereof and prior to the filing of a post-effective amendment which indicates that all securities offered have been sold or which deregisters all securities then remaining unsold. All such incorporated documents shall be deemed to be a part of this registration statement from the dates of filing such documents. </font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Any statement contained in a document incorporated or deemed to be incorporated by reference into this registration statement shall be deemed to be modified or superseded for purposes of this registration statement to the extent that a statement contained in this registration statement or in any other subsequently filed document which also is or is deemed to be incorporated into this registration statement modifies or supersedes that statement. Any </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">II-1</font></div></div></div><div id="i3f9dfcaf52544852a54ec842c06065af_148"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this registration statement.</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Item 5. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Interests of Named Experts and Counsel.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> </font></div><div style="margin-top:6pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Faraz A. Choudhry, who has given an opinion of counsel with respect to the securities to which this registration statement relates, is an employee and officer (Senior Associate General Counsel and Assistant Secretary) of the Company. Mr. Choudhry owns Company securities and is eligible to participate in various employee benefit plans of the Company, including the Plan.</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Item 6. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Indemnification of Directors and Officers.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> </font></div><div style="margin-top:6pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Delaware General Corporation Law.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As a Delaware corporation, the Company is subject to the provisions of the General Corporation Law of the State of Delaware (the &#8220;Delaware General Corporation Law&#8221;). </font></div><div style="margin-top:6pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Section 145(a) of the Delaware General Corporation Law provides that a corporation may indemnify any person who was or is a party or is threatened to be made a party to any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative (other than an action by or in the right of the corporation), by reason of the fact that the person is or was a director, officer, employee or agent of the corporation, or is or was serving at the request of the corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise, against expenses (including attorneys&#8217; fees), judgments, fines and amounts paid in settlement actually and reasonably incurred by the person in connection with such action, suit or proceeding if the person acted in good faith and in a manner the person reasonably believed to be in or not opposed to the best interests of the corporation, and, with respect to any criminal action or proceeding, had no reasonable cause to believe the person&#8217;s conduct was unlawful. The termination of any action, suit or proceeding by judgment, order, settlement, conviction or upon a plea of nolo contendere or its equivalent, shall not, of itself, create a presumption that the person did not act in good faith and in a manner which the person reasonably believed to be in or not opposed to the best interests of the corporation, and, with respect to any criminal action or proceeding, had reasonable cause to believe that the person&#8217;s conduct was unlawful.</font></div><div style="margin-top:6pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Section 145(b) of the Delaware General Corporation Law states that a corporation may indemnify any person who was or is a party or is threatened to be made a party to any threatened, pending or completed action or suit by or in the right of the corporation to procure a judgment in its favor by reason of the fact that the person is or was a director, officer, employee or agent of the corporation, or is or was serving at the request of the corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise against expenses (including attorneys&#8217; fees) actually and reasonably incurred by the person in connection with the defense or settlement of such action or suit if the person acted in good faith and in a manner the person reasonably believed to be in or not opposed to the best interests of the corporation and except that no indemnification shall be made in respect of any claim, issue or matter as to which the person shall have been adjudged to be liable to the corporation unless and only to the extent that the Delaware Court of Chancery or the court in which such action or suit was brought shall determine upon application that, despite the adjudication of liability but in view of all the circumstances of the case, the person is fairly and reasonably entitled to indemnity for such expenses as the Delaware Court of Chancery or such other court shall deem proper.</font></div><div style="margin-top:6pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Section 145(c) of the Delaware General Corporation Law provides that, to the extent that a present or former director or officer of a corporation has been successful on the merits or otherwise in defense of any action, suit or proceeding referred to in subsections (a) and (b) of Section 145, or in defense of any claim, issue or matter therein, such person shall be indemnified against expenses (including attorneys&#8217; fees) actually and reasonably incurred by such person in connection therewith.</font></div><div style="margin-top:6pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Section 145(d) of the Delaware General Corporation Law states that any indemnification under subsections (a) and (b) of Section 145 (unless ordered by a court) shall be made by the corporation only as authorized in the specific case upon a determination that indemnification of the present or former director, officer, employee or agent is proper in the circumstances because the person has met the applicable standard of conduct set forth in subsections (a) and (b) of Section 145. Such determination shall be made with respect to a person who is a director or officer at the time of such determination (1) by a majority vote of the directors who are not parties to such action, suit or proceeding, even though less than a quorum, (2) by a committee of such directors designated by majority vote of such directors, even though less than a quorum, (3) if there are no such directors, or if such directors so direct, by independent legal counsel in a written opinion or (4) by the shareholders.</font></div><div style="text-indent:18pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">II-2</font></div></div></div><div id="i3f9dfcaf52544852a54ec842c06065af_49"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Section 145(f) of the Delaware General Corporation Law states that the indemnification and advancement of expenses provided by, or granted pursuant to, the other subsections of Section 145 shall not be deemed exclusive of any other rights to which those seeking indemnification or advancement of expenses may be entitled under any bylaw, agreement, vote of shareholders or disinterested directors or otherwise, both as to action in such person&#8217;s official capacity and as to action in another capacity while holding such office.</font></div><div style="margin-top:6pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Section 145(g) of the Delaware General Corporation Law provides that a corporation shall have the power to purchase and maintain insurance on behalf of any person who is or was a director, officer, employee or agent of the corporation, or is or was serving at the request of the corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise, against any liability asserted against such person and incurred by such person in any such capacity or arising out of such person&#8217;s status as such, whether or not the corporation would have the power to indemnify such person against such liability under the provisions of Section 145.</font></div><div style="margin-top:6pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Section 145(j) of the Delaware General Corporation Law states that the indemnification and advancement of expenses provided by, or granted pursuant to, Section 145 shall, unless otherwise provided when authorized or ratified, continue as to a person who has ceased to be a director, officer, employee or agent and shall inure to the benefit of the heirs, executors and administrators of such a person.</font></div><div style="margin-top:6pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Certificate of Incorporation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company&#8217;s Certificate of Incorporation provides that, to the fullest extent permissible under the Delaware General Corporation Law, the Company&#8217;s directors shall not be personally liable to the Company or its shareholders for monetary damages for breach of fiduciary duty as a director, except that a director shall be liable to the extent provided by applicable law (1) for breach of the director&#8217;s duty of loyalty to the Company or its shareholders, (2) for acts or omissions not in good faith or which involve intentional misconduct or a knowing violation of law, (3) pursuant to Section 174 of the Delaware General Corporation Law or (4) for any transaction from which the director derived an improper personal benefit. </font></div><div style="margin-top:6pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Bylaws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company&#8217;s Bylaws provide that the Company shall indemnify and hold harmless, to the fullest extent permitted by applicable law, any person who was or is made or is threatened to be made a party or is otherwise involved in any threatened, pending, or completed action, suit or proceeding because he or she, or a person for whom he or she is the legal representative, is or was a director or officer of the Company or, while a director or officer of the Company, is or was serving at the request of the Company as a director, officer, employee or agent of another corporation, partnership, joint venture, trust, enterprise or nonprofit entity against all liability and loss suffered and expenses (including attorneys&#8217; fees) reasonably incurred by such person.</font></div><div style="margin-top:6pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company&#8217;s Bylaws provide that the Company shall advance to indemnified persons expenses incurred in defending any such proceedings, subject to an obligation to repay amounts so advanced if it shall ultimately be determined by final judicial decision from which there is no further right to appeal that such indemnified person is not entitled to be indemnified for such expenses under the Company&#8217;s Bylaws or otherwise. </font></div><div style="margin-top:6pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Indemnification Agreements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company has entered into an indemnification agreement with each of its directors and executive officers which provides, among other things, that the Company will indemnify each such person to the fullest extent permitted by law, subject to certain conditions, against all expenses and certain other amounts actually and reasonably incurred by such person in connection with proceedings in which such person is involved, or is threatened to become involved, because such person is or was a director or officer of the Company, by reason of any action or inaction on the part of such person, or by reason of the fact that such person is or was serving at the request of the Company as a director, officer, trustee, partner, managing member, fiduciary, employee or agent of any other enterprise. The indemnification agreement also requires the Company, under certain circumstances, to advance expenses incurred by such person in connection with the investigation, defense, settlement or appeal of any such proceedings. </font></div><div style="margin-top:6pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Liability Insurance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company maintains directors&#8217; and officers&#8217; liability insurance which covers certain liabilities and expenses of the Company&#8217;s directors and officers and covers the Company for reimbursement of payments to the Company&#8217;s directors and officers in respect of such liabilities and expenses.</font></div><div id="i3f9dfcaf52544852a54ec842c06065af_102"></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">II-3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="-sec-extract:summary"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Item 8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Exhibits.</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:9.904%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.437%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.259%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Number</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Description</font></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a href="http://www.sec.gov/Archives/edgar/data/731766/000073176615000027/unhex31delawarecertificate.htm" style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">4.1</a></font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a href="http://www.sec.gov/Archives/edgar/data/731766/000073176615000027/unhex31delawarecertificate.htm" style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Certificate of Incorporation of UnitedHealth Group Incorporated (incorporated by reference to Exhibit 3.1 to UnitedHealth Group Incorporated&#8217;s Registration Statement on Form 8-A&#47;A, Commission File No. 1-10864, filed on July 1, 2015).</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a href="http://www.sec.gov/Archives/edgar/data/731766/000073176621000010/bylawsexhibit.htm" style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">4.2</a></font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a href="http://www.sec.gov/Archives/edgar/data/731766/000073176621000010/bylawsexhibit.htm" style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Amended and Restated Bylaws of UnitedHealth Group Incorporated, effective February 23, 2021 (incorporated by reference to Exhibit 3.2 to UnitedHealth Group Incorporated&#8217;s Current Report on Form 8-K, Commission File No. 1-10864, filed on February 26, 2021).</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a href="exhibit43espp.htm" style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">4.3</a></font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a href="exhibit43espp.htm" style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">UnitedHealth Group 1993 Employee Stock Purchase Plan, as amended and restated effective as of June 7, 2021.</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a href="exhibit51espp.htm" style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">5.1</a></font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a href="exhibit51espp.htm" style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Opinion of Faraz A. Choudhry, the Company&#8217;s Senior Associate General Counsel.</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a href="exhibit51espp.htm" style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">23.1</a></font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a href="exhibit51espp.htm" style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Consent of Faraz A. Choudhry, the Company&#8217;s Senior Associate General Counsel (included in Exhibit 5.1).</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a href="exhibit232espp.htm" style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">23.2</a></font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a href="exhibit232espp.htm" style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Consent of Deloitte &#38; Touche LLP.</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a href="exhibit241espp.htm" style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">24.1</a></font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a href="exhibit241espp.htm" style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Power of Attorney.</a></font></div></td></tr></table></div><div id="i3f9dfcaf52544852a54ec842c06065af_118"></div><div style="text-indent:18pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">II-4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Item 9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Undertakings.</font></div><div style="margin-top:6pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">   </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The undersigned registrant hereby undertakes&#58;</font></div><div style="margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">   </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement&#58;</font></div><div style="margin-top:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">    </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">To include any prospectus required by section 10(a)(3) of the Securities Act of 1933&#59;</font></div><div style="margin-top:6pt;padding-left:27pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">   </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than a 20% change in the maximum aggregate offering price set forth in the &#34;Calculation of Registration Fee&#34; table in the effective registration statement&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="margin-top:6pt;padding-left:27pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">To include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information in the registration statement&#59;</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Provided, however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, that paragraphs (a)(1)(i) and (a)(1)(ii) of this section do not apply if the information required to be included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the Commission by the registrant pursuant to section 13 or section 15(d) of the Securities Exchange Act of 1934 that are incorporated by reference in the registration statement.</font></div><div style="margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">   </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">That, for the purpose of determining any liability under the Securities Act of 1933, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">bona fide</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> offering thereof.</font></div><div style="margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">   </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.</font></div><div style="margin-top:6pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">   </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The undersigned registrant hereby undertakes that, for purposes of determining any liability under the Securities Act of 1933, each filing of the registrant&#8217;s annual report pursuant to section 13(a) or section 15(d) of the Securities Exchange Act of 1934 (and, where applicable, each filing of an employee benefit plan&#8217;s annual report pursuant to section 15(d) of the Securities Exchange Act of 1934) that is incorporated by reference in the registration statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">bona fide</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> offering thereof.</font></div><div style="margin-top:6pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">   </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Insofar as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers and controlling persons of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Act and will be governed by the final adjudication of such issue.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">II-5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:6pt;text-indent:18pt"><font><br></font></div><div id="i3f9dfcaf52544852a54ec842c06065af_135"></div><div style="text-align:center;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">SIGNATURES</font></div><div><font><br></font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Minnetonka, State of Minnesota, on October 29, 2021.</font></div><div style="text-indent:234pt"><font><br></font></div><div style="text-align:right;text-indent:234pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:50.000%"><tr><td style="width:1.0%"></td><td style="width:7.874%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.926%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">UNITEDHEALTH GROUP INCORPORATED</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; ANDREW P. WITTY</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Andrew P. Witty</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td></tr></table></div><div style="margin-bottom:15pt;margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the capacities indicated on October 29, 2021. </font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.778%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.082%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.740%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Signature</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Title</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"><div style="text-align:center"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; ANDREW P. WITTY</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Director and Chief Executive Officer<br>(principal executive officer)</font></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Andrew P. Witty</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; JOHN F. REX</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Chief Financial Officer<br>(principal financial officer)</font></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">John F. Rex</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; THOMAS E. ROOS</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Senior Vice President and Chief Accounting Officer<br>(principal accounting officer)</font></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Thomas E. Roos</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">*</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Director</font></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Richard T. Burke</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">*</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Director</font></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Timothy P. Flynn</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">*</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Director</font></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Stephen J. Hemsley</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">*</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Director</font></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Michele J. Hooper</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:10pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">*</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Director</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">F. William McNabb III</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">*</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Director</font></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Valerie C. Montgomery Rice</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">*</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Director</font></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">John H. Noseworthy, M.D.</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">*</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Director</font></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Gail R. Wilensky, Ph.D.</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">II-6</font></div></div></div><div id="i3f9dfcaf52544852a54ec842c06065af_178"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:1.944%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.203%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.453%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The undersigned, by signing below, does hereby execute this registration statement on behalf of the directors of UnitedHealth Group Incorporated listed above pursuant to the Power of Attorney filed herewith as Exhibit 24.1.</font></div></td></tr></table></div><div style="margin-top:12pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:64.583%"><tr><td style="width:1.0%"></td><td style="width:29.669%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.607%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:62.424%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; FARAZ A. CHOUDHRY</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Faraz A. Choudhry</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">As Attorney-In-Fact</font></td></tr></table></div><div style="text-indent:288pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">           </font></div><div style="text-indent:288pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">           </font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">II-7</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.3
<SEQUENCE>2
<FILENAME>exhibit43espp.htm
<DESCRIPTION>EX-4.3
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i89601124e7e74bd0979fb250ba809f9f_33"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Exhibit 4.3</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">UNITEDHEALTH GROUP 1993 </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">EMPLOYEE STOCK PURCHASE PLAN                  </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Amended and Restated Effective June 7, 2021</font></div><div style="margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">ARTICLE I </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">PURPOSE</font></div><div style="margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Section 1.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. The purpose of the UnitedHealth Group 1993 Employee Stock Purchase Plan (the &#8220;Plan&#8221;) is to enhance employee commitment to the goals of the Company, by providing a means of achieving stock ownership on advantageous terms to eligible employees of the Company or a Participating Affiliate.</font></div><div style="margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">ARTICLE II </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">DEFINITIONS</font></div><div style="margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Section 2.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. For purposes of the Plan the following terms shall be defined as follows&#58;</font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:5.8pt">&#8220;Adoption Date&#8221; means February 9, 2011.</font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:5.18pt">&#8220;Affiliate&#8221; means any subsidiary corporation of the Company, as defined in Section 424(o) of the Code, whether now or hereafter acquired.</font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:5.8pt">&#8220;Board of Directors&#8221; means the Board of Directors of UnitedHealth Group Incorporated.</font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:5.18pt">&#8220;Code&#8221; means the Internal Revenue Code of 1986, as amended from time to time.  References to the Code shall include all regulations and other binding interpretive authority issued pursuant to the Code.</font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:5.8pt">&#8220;Code Section 423 Plan&#8221; means an employee stock purchase plan which is designed to meet the requirements set forth in Section 423 of the Code, as amended. The provisions of the Code Section 423 Plan shall be construed, administered and enforced in accordance with Section 423.</font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:6.03pt">&#8220;Common Stock&#8221; means the Common Stock, par value $.01 per share, of UnitedHealth Group Incorporated.</font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:4.02pt">&#8220;Committee&#8221; means the Compensation and Human Resources Committee of the Company&#8217;s Board of Directors, or such successor committee as is made up of three or more directors of the Company, none of whom shall be officers or employees of the Company and all of whom shall be &#8220;Non-Employee Directors&#8221; with respect to the Plan within the meaning of Rule 16(b)-3 under the Securities Exchange Act of 1934, as amended, and any successor rule.</font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:4.02pt">&#8220;Company&#8221; means UnitedHealth Group Incorporated, or any company that assumes and succeeds to the obligations of UnitedHealth Group Incorporated under the Plan.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:6pt"><font><br></font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:6.69pt">&#8220;Compensation&#8221; means the Eligible Employee&#8217;s annualized rate of salary, or regular hourly compensation,  in effect at any time during an Offering Period, exclusive of all overtime earnings, shift differentials, commissions, bonus payments, the value of fringe or welfare benefits and all other forms of remuneration (but including any elective contributions to employee benefit plans withheld from the Eligible Employee&#8217;s Compensation).</font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:6.69pt">&#8220;Eligible Employees&#8221; means all employees of the Company or a Participating Affiliate except (i) employees customarily employed less than twenty (20) hours weekly&#59; (ii) employees whose customary employment is for not more than 5 months in any calendar year&#59; and (iii) employees who, immediately after a right to purchase is granted, would be deemed for purposes of Section 423(b)(3) of the Code to own stock possessing five percent (5%) or more of the total combined voting power or value of all classes of the shares of the Company.</font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">(k)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:4.02pt">&#8220;Maximum Offering&#8221; shall mean, with respect to some or all participants in the Non-423 Plan, a maximum number or value of shares of the Company stock made available for purchase in specified countries, locations or Participating Affiliates. Such maximum shall be determined by the Committee or its designate to comply with securities laws, to achieve tax objectives or to meet other Company objectives.</font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">(l)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:6.69pt">&#8220;Non-423 Plan&#8221; means an employee stock purchase plan which does not meet the requirements set forth in Section 423 of the Code, as amended.</font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">(m)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:0.69pt">&#8220;Participant&#8221; means an Eligible Employee who has elected to participate in the Plan in the manner set forth in the Plan, and whose participation in the Plan has not ended as set forth in and pursuant to Article VII.</font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">(n)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:4.02pt">&#8220;Participating Affiliate&#8221; means an Affiliate which has been designated by the Committee in advance of the Purchase Period in question as a corporation whose Eligible Employees may participate in the Plan. The Committee may determine that employees of any Participating Affiliate shall participate in the Non-Section 423 Plan. </font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">(o)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:4.02pt">&#8220;Plan&#8221; means the UnitedHealth Group 1993 Employee Stock Purchase Plan, Amended and Restated as of June 7, 2021, which includes a Code Section 423 Plan and a Non-423 Plan component.</font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">(p)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:4.02pt">&#8220;Plan Year&#8221; means the twelve month period, beginning January 2, 1999, that commences each January 2 and ends on January l of the next succeeding year.</font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">(q)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:4.02pt">&#8220;Purchase Date&#8221; means the last day of a Purchase Period.</font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">(r)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:6.03pt">&#8220;Purchase Period&#8221; means each of the two 26 week periods in each Plan Year, i.e. the 26-week period from January 2 to July 1 and the 26-week period from July 2 to January 1, during the term of this Plan and during which time payroll deductions are made from the Compensation of Eligible Participants  in the Plan.  The Committee may specify </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:6pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Purchase Periods of different duration from time to time.  Each Purchase Period shall constitute a separate &#8220;offering&#8221; of shares for purposes of Code Section 423 and the regulations thereunder.  </font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">(s)&#8220;Stock Purchase Account&#8221; means the individual account established by the Company for each Participant to which payroll deductions are credited.</font></div><div style="margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">ARTICLE III </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">ELIGIBLE EMPLOYEES&#59; ELECTION TO PARTICIPATE&#59; PAYROLL </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">DEDUCTIONS</font></div><div style="margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Section 3.01</font></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:10.37pt;text-decoration:underline">Election to Participate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. Each Eligible Employee may elect to participate in the Plan by completing the appropriate enrollment forms and procedures by the enrollment deadline established  for  a Purchase Period. The enrollment procedures will authorize regular payroll deductions from the employee&#8217;s Compensation, such deductions to begin with the first payroll period ending on or after the beginning of the first Purchase Period after the Eligible Employee enrolls in the Plan.</font></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:9pt;text-decoration:underline">Contribution and Payroll Deduction Election</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. A Participant may elect contributions and payroll deductions from his or her Compensation in whole percentages not less than one percent (1%) or more than ten percent (10%) of his or her Compensation.</font></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:9.68pt;text-decoration:underline">Change in Payroll Deduction Election</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. A Participant may not increase his or her contributions and payroll deductions during a Purchase Period. A Participant may discontinue contributions and payroll deductions during a Purchase Period as explained in Section 7.02.a. A Participant may increase or reduce his or her contributions and payroll deductions for a future Purchase Period as explained in Section 7.02.b.</font></div><div style="margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">ARTICLE IV </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">PAYROLL DEDUCTIONS&#59; STOCK PURCHASE ACCOUNT</font></div><div style="margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Section 4.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.  Payroll deductions shall be credited to the Participant&#8217;s Stock Purchase Account. A Participant may not make any separate cash payment into his or her Stock Purchase Account.</font></div><div style="margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Section 4.02</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.  The Stock Purchase Account is established solely for accounting purposes, and all amounts credited to the Stock Purchase Account will remain part of the general assets of the Company, or the Participating Affiliate (as the case may be). No amounts credited to any Participant&#8217;s Stock Purchase Account nor any benefit received by a Participant under the Plan shall be subject to the debts, contracts, liabilities, engagements or torts of the Participant. No interest shall be paid on amounts credited to a Participant&#8217;s Stock Purchase Account.</font></div><div style="margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Section 4.03</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. Participants are responsible for paying all income taxes, employment, social insurance, welfare and other taxes under applicable law relating to any amounts </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">deemed under the laws of the country of their residence or of the organization of the Participating Affiliate which employs them to constitute (i) income arising out of the Plan, (ii) the purchase and sale of shares of Common Stock pursuant to the Plan and the distribution of Common Stock or (iii) cash to the Participant in accordance with this Plan. By participating in the Plan, each Participant authorizes the relevant Participating Affiliate to make appropriate withholding deductions from the Participant&#8217;s compensation, which shall be in addition to any payroll deductions made pursuant to Section 4.01, and to pay such amounts to the tax authorities in the relevant country or countries in order to satisfy any of the above tax liabilities of the Participant under applicable law.</font></div><div style="margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">ARTICLE V </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">PURCHASE PRICE</font></div><div style="margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Section 5.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. Subject to the provision of Section 7.01.b.ii., each Participant shall have the right to purchase on the Purchase Date for the applicable Purchase Period, that number of whole and fractional shares of Common Stock as can be purchased at a price equal to the price specified in Section 5.02 on such date, with the funds then present in the Participant&#8217;s Stock Purchase Account on the last day of such Purchase Period&#59; provided, however, that no Participant shall be allowed to purchase more than 1,000 shares in any one Purchase Period, except as otherwise determined pursuant to Section 11.01.  No Participant shall be allowed to purchase Common Stock under the Code Section 423 Plan (and under all other employee stock purchase plans, if any, of the Company and any Affiliate) at a rate which exceeds $25,000 in fair market value of Common Stock (determined on the date on which Eligible Employees are treated as having been granted the option to purchase shares for tax purposes) in any calendar year.</font></div><div style="margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">If Participants elect during any given Purchase Period to purchase shares of Common Stock which would result in aggregate elections to purchase more than the number of shares of Common Stock then available under the Plan, the Committee will allocate the remaining shares of Common Stock available under the Plan, on a pro rata basis, in accordance with the elections previously filed by each Participant.</font></div><div style="margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Section 5.02</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.  The purchase price shall be 90% of the fair market value of the Common Stock on the last day of the applicable Purchase Period, rounded up to the next higher full cent. The fair market value on any day shall be (i) the closing price of the Common Stock as reported for composite transactions if the Common Stock is then traded on a national securities exchange&#59; (ii) the last sale price if the Common Stock is then quoted on the NASDAQ National Market&#59; or (iii) the average of the closing representative bid and asked prices if the Common Stock is then reported on NASDAQ, in each case on the date as of which the fair market value is being determined. If the Common Stock is not traded, quoted or reported on any of the above exchanges or reporting systems on such date, the Committee shall make a good faith attempt to establish the fair market value of the Common Stock and in connection therewith shall take such action as it deems necessary or advisable. If the last day of any Purchase Period is a Saturday, Sunday or holiday on which NASDAQ or the applicable national securities exchange is closed, the fair market value shall be </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">determined as of the immediately preceding day on which the NASDAQ or the applicable national securities exchange was open.</font></div><div style="margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">ARTICLE VI </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">PURCHASE</font></div><div style="margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Section 6.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. Except as provided in Section 7.01, on the Purchase Date for each Purchase Period, the funds in each Participant&#8217;s Stock Purchase Account shall be used to purchase the largest number of whole and fractional shares of Common Stock that can be purchased with such funds (taking into account the limitations set forth in Section 5.01).</font></div><div style="margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Section 6.02</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. Any funds remaining in a Participant&#8217;s Stock Purchase Account after each such purchase shall be refunded to him or her as soon as practicable after the end of the applicable Purchase Period.</font></div><div style="margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">ARTICLE VII </font></div><div style="margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">RENEWAL OF ELECTION TO CONTRIBUTE&#59; ELECTION TO DISCONTINUE CONTRIBUTIONS&#59; TERMINATION OF RIGHT TO CONTRIBUTE&#59; </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">TERMINATION OF RIGHT TO PURCHASE COMMON STOCK</font></div><div style="margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Section 7.01</font></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:10.37pt;text-decoration:underline">Automatic Renewal of Election to Contribute</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. Once an Eligible Employee becomes a Participant, his or her contribution and payroll deduction election remains in effect from Purchase Period to Purchase Period , and is automatically renewed, except as provided in Section 7.02.a, until the Participant&#8217;s right to contribute to the Plan ends as provided in Section 7.01.b.i.  Notwithstanding the foregoing, the Committee may provide that separate elections shall be required for any subsequent Purchase Period.</font></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:9.75pt;text-decoration:underline">Termination of Right to Participate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.</font></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:11.67pt;text-decoration:underline">Termination of Right to Contribute</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. A Participant&#8217;s right to contribute to the Plan ends as of the date on which he or she (a) no longer is an Eligible Employee, (b) is no longer employed by the Company or a Participating Affiliate, or (c) elects to discontinue contributions as provided in Sections 7.02.a or b.</font></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">ii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:8.34pt;text-decoration:underline">Termination of Right to Purchase</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. When a Participant&#8217; s right to contribute to the Plan ends because he or she (a) no longer is an Eligible Employee, or (b) is no longer employed by the Company or a Participating Affiliate, the Participant&#8217;s  right to  purchase Common  Stock for the current Purchase Period ends at the same time.</font></div><div style="margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Section 7.02</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.</font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:10.37pt;text-decoration:underline">Election to Discontinue Contributions For Remainder of Current Purchase Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:6pt"><font><br></font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:11.67pt">Each Participant has the right to elect to discontinue contributions to the Plan up to and until the last day of the fifth month of the current Purchase Period. Such election must be made in accordance with the Company&#8217;s administrative procedures and shall be effective with the first payroll period that is administratively feasible following the receipt of the Participant&#8217;s election, and shall be irrevocable for the remainder of the current Purchase Period.</font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">ii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:8.34pt">The Participant&#8217;s contributions, made during the current Purchase Period, will be used to purchase Common Stock on the Purchase Date for the current Purchase Period, unless the Participant elects a refund pursuant to Section 7.02.c.</font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:9.75pt;text-decoration:underline">Election to Increase, Decrease or Discontinue Contributions in Future Purchase Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. Each Participant has the right to elect to increase, decrease or discontinue contributions to the Plan effective as of the next succeeding Purchase Period. Such election must be made in accordance with the Company&#8217;s administrative procedures, shall be effective with the first payroll period in the subsequent Purchase Period. Except as provided in Section 7.02.a.i, such election shall be irrevocable for the duration of the subsequent Purchase Period.</font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:10.37pt;text-decoration:underline">Election  of Refund of Uninvested  Contributions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. Each Participant has the right to elect to have the funds that exist in his or her Stock Purchase Account up to and until the last day of the fifth month of the Purchase Period refunded to him or her instead of being used to purchase Common Stock&#59; notwithstanding, the Committee shall have the administrative discretion to alter this date in accordance with Section 11.01. Such election shall be made in accordance with the Company&#8217;s administrative procedures. Such refund will be made as provided in Section 7.03.</font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:9.75pt;text-decoration:underline">Election to Resume Contributions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. A Participant who elects in accordance with Section 7.02.a.i to discontinue contributions to the Plan for the remainder of a current Purchase Period may elect to resume contributions to the Plan only for a subsequent Purchase Period, and such election must be made in accordance with the Company&#8217;s administrative procedures.</font></div><div style="margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Section 7.03</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Timing of Refund of Uninvested Contributions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. When a Participant&#8217;s right to purchase Common Stock ends as provided in Section 7.01.b, or when a Participant elects a refund of uninvested contributions pursuant to Section 7.02.c, the Company shall refund in cash to the Participant all uninvested contributions that remain in the Participant&#8217;s Stock Purchase Account. Such refund will be made as soon as is administratively feasible and in accordance with the Company&#8217;s administrative procedures.</font></div><div style="margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">ARTICLE VIII </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">TRANSFERABILITY</font></div><div style="margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. A Participant&#8217;s rights hereunder are exercisable during his or her lifetime only by him or her and may not be assigned, transferred, pledged or hypothecated </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">(whether by operation of law or otherwise) in any manner, other than by will  or the laws of descent and distribution and shall not be subject to execution, attachment or similar process. Any attempted assignment, transfer, pledge, hypothecation or other disposition or levy of attachment or similar process upon the right to purchase shall be null and void and without effect.</font></div><div style="margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Section 8.02</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.  The funds accumulated in a Stock Purchase Account may not be assigned, transferred, pledged or hypothecated in any way, and any attempted assignment, transfer, pledge, hypothecation or other disposition of the funds accumulated in the Stock Purchase Account shall be null and void and without effect.</font></div><div style="margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">ARTICLE IX </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">ACCOUNT STATEMENTS&#59; CERTIFICATES</font></div><div style="margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Section 9. 01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. As soon as practicable after each Purchase Period the Company will cause to be delivered to the Participant an account statement describing the Common Stock purchased with respect to such Purchase Period. Upon request from the Participant, as soon as practicable after each Purchase Period the Company shall cause to be delivered to the Participant a Certificate representing the Common Stock purchased.</font></div><div style="margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Section 9.02</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. The Company shall not be required to issue any Common Stock purchased hereunder prior to registration under the Securities Act of 1933, as amended, or registration, or qualification under any state law if such registration is required.</font></div><div style="margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Section 9.03</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. A Participant shall have no interest in, and will not be entitled to any of the rights or privileges of a shareholder of the Company with respect to the Common Stock purchased by him or her pursuant to the Plan, including the right to receive any dividends which may be declared by the Company, until such time as he or she has actually paid the purchase price for the shares and the Company has so credited the Participant&#8217;s Stock Purchase Account.  Cash dividends received in respect of Common Stock held in a Participant&#8217;s Stock Purchase Account shall be credited to the Participant&#8217;s Stock Purchase Account, net of applicable United States withholding taxes on such dividends, which shall be withheld by the Company and paid to the appropriate United States tax authorities.  Such cash dividends may either be (i) reinvested in shares of Common Stock as promptly as practicable following crediting thereof, or (ii) held as cash in the Participant&#8217;s Stock Purchase Account.  The Company or the Participating Affiliate employing the Participant shall notify each Participant annually as part of its periodic reporting obligations of the amount of such US tax withholding applicable to each Participant&#8217;s Stock Purchase Account in order to enable the Participant to apply for any applicable tax credit in the Participant&#8217;s country of residence.</font></div><div style="margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Section 9.04</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.  The Common Stock issued under the Plan shares. shall be registered in the name of the Participant purchasing such shares.  Notwithstanding the foregoing, the Committee may provide for shares purchased under the Plan to be held in a brokerage account in the name of the Participant with a broker designated by the Plan.</font></div><div style="margin-top:6pt;text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">ARTICLE X </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">AMENDMENT&#59; TERMINATION OF PLAN</font></div><div style="margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Section 10.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. The Board of Directors of the Company may at any time terminate or amend the Plan except that no amendment shall be made without prior approval of the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">shareholders which would (i) authorize  an increase in the number  of shares which may be purchased under the Plan, except as provided in Section 12.01&#59; (ii) permit the issuance of Common Stock before payment therefore in full&#59; (iii) increase the rate of payroll  deductions above ten percent (10%) of Compensation&#59; (iv) reduce the price per share at which Common Stock may be purchased below 85% of the lower of the fair market value of the Common Stock on the first or last day of the applicable Offering Period&#59; (v)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">withdraw administration of the Plan from the Committee&#59; or (vi) change the definition of subsidiaries eligible to participate in the Plan.</font></div><div style="margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Section 10.02</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.  The Plan may be terminated (i) on the day when no further shares of Common Stock remain under the Plan&#59; or (ii) at any time in the discretion of the Board of Directors after 30 days&#8217; notice has been given to Eligible Employees. Upon termination of the Plan, the applicable Purchase Period shall be deemed closed, and shares of Common Stock will be issued to Participants in accordance with Section 5.01.</font></div><div style="margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">ARTICLE XI </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">ADMINISTRATION</font></div><div style="margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Section 11.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. The Plan shall be administered by the Committee which is authorized to interpret and construe any provision of the Plan, to establish deadlines and procedures by which the various administrative processes must be completed in order to be effective and to adopt such other rules and regulations for administering the Plan as it may deem appropriate. The Committee shall, to the extent necessary or desirable, establish any special rules for Eligible Employees, former employees, or Participants located in any particular country other than the United States.  In administering the Plan, it may be necessary, from time to time, to change or waive requirements of the Plan to conform with the law, to meet special circumstances not anticipated or covered in the Plan, or to carry on successful operations of the Plan.  Therefore, the Company reserves the right, exercisable by the Committee, to make variations in the provisions of the Plan for such purposes.  Without limiting the generality of the foregoing, the Committee may, in its sole discretion, alter the time and duration of Purchase Periods and the procedures for making, revising and terminating participation elections (including the extent to which elections are applicable to future Offering Periods), may change the maximum number of shares of Common Stock that may be purchased in an Offering Period (subject to Section 423 of the Code), and may change the purchase price for shares of Common Stock provided that the purchase price is not reduced below the price specified in Section 10.01.iv.  Any such change that is communicated to Eligible Employees shall be deemed to an exercise of the Committee&#8217;s authority to make variations in the provisions of the Plan without the need for formal amendment.  The Committee will determine any questions arising in the administration, interpretations and application of the Plan, and all determinations will be conclusive and binding on all parties.  </font></div><div style="margin-top:6pt;text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">ARTICLE XII </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">STOCK DIVIDEND OR RECLASSIFICATION&#59; MERGER OR CONSOLIDATION</font></div><div style="margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Section 12.0l</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.  If a record date for a stock dividend, stock-split or for a reclassification by way of split-up or reduction in the number of shares of Common Stock shall occur during a Purchase Period, appropriate adjustments in the number of shares of Common Stock and purchase prices shall be made to give effect thereto on an equitable basis. Similarly, on the payment of any stock dividend, stock-split or reclassification by way of split-up or reduction in  the number of shares, the total number of shares authorized by Section 14.01 to be sold under the Plan shall be adjusted accordingly.</font></div><div style="margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Section 12.02</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.  If the Company is merged into or consolidated with one or more corporations during a Purchase Period, appropriate adjustments shall be made to give effect thereto on an equitable basis in terms of issuance of shares of the corporation surviving the merger or of the consolidated corporation, as the case may be.</font></div><div style="margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">ARTICLE XIII </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">CHANGE IN CONTROL</font></div><div style="margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Section 13.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. A &#8220;Change in Control&#8221; shall mean the sale of all or substantially all of the Company&#8217;s assets or any merger, reorganization, or exchange or tender offer which, in each case, will result in a change in the power to elect 50% or more of the members of the Board of Directors of the Company.</font></div><div style="margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Section 13.02</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.</font></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:10.37pt;text-decoration:underline">Rights and Obligations Under the Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. In the event of a Change in Control, the surviving, continuing, successor, or purchasing corporation or parent corporation thereof, as the case may be, which may be the Company (the &#8220;Acquiring Corporation&#8221;), may assume the Company&#8217;s rights and obligations under the Plan.  If the Acquiring Corporation elects not to assume the Company&#8217;s rights and obligations under the Plan and with respect to Participants&#8217; right to purchase stock, the Purchase Date of the then current Purchase Period shall be accelerated to a date before the date of the Change in Control specified by the Committee, but the number of shares of Common Stock that may be purchased with the outstanding funds accumulated in the Stock Purchase Account shall not be adjusted.</font></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:9.75pt;text-decoration:underline">Non-423 Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. Notwithstanding Section 13.02.a, the Purchase Date with respect to Participants&#8217; rights to purchase Common Stock granted pursuant to a Non-423 Plan to a Participant who would otherwise be subject to Code Section 409A shall be accelerated as contemplated by the foregoing sentence only to the extent the event constituting the Change in Control qualifies as a &#8220;change in ownership&#8221; or &#8220;change in effective control&#8221; of the Company or a &#8220;change in ownership of a substantial portion of the assets&#8221; of the Company, as these concepts are defined in U.S. Treas. Reg. &#167;1.409A-3(i)(5) or successor provisions.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:6pt;padding-left:36pt"><font><br></font></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:10.37pt;text-decoration:underline">Termination of Purchase Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. All Participants&#8217; rights to purchase Common Stock which are neither assumed by the Acquiring Corporation in connection with the Change in Control nor exercised as of the date of the Change in Control shall terminate and cease to be outstanding effective as of the date of the Change in Control, and all remaining funds in Participants&#8217; Stock Purchase Accounts shall be refunded as soon as practical.</font></div><div style="margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">ARTICLE XIV </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">SHARES TO BE SOLD</font></div><div style="margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Section 14.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. The Common Stock to be issued and sold under the Plan may be authorized but unissued shares, or the Company may go into the market and purchase shares for sale under the Plan. Except as provided in Section 12.01, the aggregate number of shares of authorized but unissued Common Stock to be sold under the Plan on or after the Adoption Date shall not exceed 50,000,000. If on a given Purchase Date the number of shares to be purchased exceeds the number of shares then available under the Plan or the Maximum Offering, if any, that may be issued on any given Purchase Date, the Company shall make a pro rata allocation of the shares remaining available for purchase in as uniform a manner as shall be practicable and as it shall determine to be equitable. The pro rata allocation shall be limited, in the case of exceeding the Maximum Offering, to those Participants in the countries, locations or Participating Affiliates in the specified Maximum Offering.</font></div><div style="margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">ARTICLE XV </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">NOTICES&#59; CONSTRUCTION</font></div><div style="margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Section 15.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. Notices to the Company under the Plan shall be addressed to the address shown below, and notice to an Eligible Employee or Participant shall be addressed to the Eligible Employee&#8217;s or Participant&#8217;s last address as reflect on the personnel records of the Company or the Participating Affiliate employing such person.</font></div><div style="margin-top:6pt;text-align:center;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">UnitedHealth Group Incorporated </font></div><div style="text-align:center;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Attention&#58; Corporate Benefits - ESPP  </font></div><div style="text-align:center;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">UnitedHealth Group Center 9900 Bren Road East </font></div><div style="text-align:center;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Minnetonka, Minnesota 55343</font></div><div style="margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Section 15.02</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. The Company intends that the Code Section 423 Plan qualify as an &#8220;employee stock purchase plan&#8221; under Section 423 of the Code and, therefore, the Plan shall be construed in a manner consistent therewith. All Participants in the Code Section 423 Plan shall have the same rights and privileges under the terms of the Code Section 423 Plan.</font></div><div style="margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">ARTICLE XVI </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">GOVERNMENTAL REGULATIONS AND LISTING</font></div><div style="margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Section 16.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. All rights granted to Participants under this Plan are expressly subject to all applicable laws, regulations and the approval of all governmental authorities required </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">for the authorization, issuance, sale or transfer of the shares of Common Stock reserved for the Plan. This includes, without limitation, a current registration statement of the Company under the Securities Act of 1933, as amended, covering the shares of Common Stock that may be purchased under the Plan. If a registration statement is not effective on the last day of a Purchase Period, the Purchase Period shall be extended until the first business day after the effective date of a registration statement, or post-effective amendment&#59; provided, however, that a Purchase Period for a Participant in a Non-423 Plan who would otherwise be subject to Section 409A of the Code shall be extended only to the extent that such extension would not cause a violation under Section 409A of the Code.</font></div><div style="margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">ARTICLE XVII </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">MISCELLANEOUS</font></div><div style="margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Section 17.01.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  This Plan will not be deemed to constitute a contract of employment between the Company or a Participating Affiliate and any Eligible Employee, nor will it interfere with the right of the Company to terminate any Eligible Employee and treat him or her without regard to the effect that termination might have upon him or her under the Plan. Nothing in this Plan shall confer on any Participant (i) any express or implied right to continued employment by the Company or any Affiliate, whether for the duration of the Plan or otherwise, (ii) legal or equitable right against the Company or any Affiliate, directly or indirectly or (iii) cause of action at law or equity against the Company or any Affiliate. Neither the Common Stock acquired under this Plan nor any other benefits conferred hereby, including the acquisition of Common Stock at a discount, will form any part of the wages or salary of any Eligible Employee for purposes of severance pay or termination  indemnities, irrespective of the reason for termination of employment. Under no circumstances shall any person ceasing to be an employee of the Company or any Affiliate be entitled to any compensation for any loss of any right or benefit under this Plan which such employee might otherwise have enjoyed but for termination of employment, whether such compensation is claimed by way of damages for wrongful or unfair dismissal, breach of contract or otherwise.</font></div><div style="margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Section 17.02</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. By participating in the Plan, each Participant shall be deemed to have accepted all the conditions of the Plan and the terms and conditions of any rules and regulations adopted by the Committee and shall be fully bound thereby.</font></div><div style="margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Section 17.03</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. The Code Section 423 Plan is exempt from the application of Section 409A of the Code. The Non-423 Plan is intended to comply and shall be administered in a manner that is intended to comply with Section 409A of the Code  and shall be construed and interpreted in accordance with such intent. To the extent an option or rights under the Non-423 Plan or the vesting, payment, settlement or deferral thereof is subject to Section 409A of the Code, the option or right shall be granted, paid, exercised, settled or deferred in a manner that will comply with Section 409A of the Code, including the final regulations and other guidance issued with respect thereto, except as otherwise determined by the Committee. Any provision of the Non-423 Plan that would cause the grant of an option or right or the payment, settlement or deferral thereof to fail to satisfy Section 409A of the Code shall be </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">amended to comply with Section 409A of the Code on a timely basis, which amendment may be made on a retroactive basis, in accordance with the final regulations and guidance issued under Section 409A of the Code.  Notwithstanding the foregoing, the Company shall have no liability to a Participant or any other party if an option or right granted under the Plan that is intended to be exempt from, or compliant with Section 409A of the Code is not so exempt or compliant or for any action (or failure to act) taken by the Committee with respect thereto. </font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>3
<FILENAME>exhibit51espp.htm
<DESCRIPTION>EX-5.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i4f4d2a0ac2ce4e1e93170d97c48eb40b_33"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:110%">Exhibit 5.1</font></div><div style="text-align:right"><img alt="uhglogoa06.jpg" src="uhglogoa06.jpg" style="height:44px;margin-bottom:5pt;vertical-align:text-bottom;width:250px"></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">October 29, 2021</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">Board of Directors</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">UnitedHealth Group Incorporated</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">9900 Bren Road East</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">Minnetonka, Minnesota 55343</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">Ladies and Gentlemen&#58;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">I have acted as Senior Associate General Counsel to UnitedHealth Group Incorporated, a Delaware corporation (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:110%">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">&#8221;), in connection with the preparation of its registration statement on Form S-8 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:110%">Registration Statement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">&#8221;), filed with the Securities and Exchange Commission under the Securities Act of 1933, as amended (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:110%">Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">&#8221;), relating to the proposed offering of up to 15,000,000 shares of common stock, par value $0.01 per share (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:110%">Common Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">&#8221;), of the Company (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:110%">Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">&#8221;), all of which shares are issuable pursuant to the Employee Stock Purchase Plan (as in effect on the date hereof, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:110%">Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">&#8221;).  This opinion letter is furnished to you at your request to enable you to fulfill the requirements of Item 601(b)(5) of Regulation S&#8209;K, 17 C.F.R. &#167; 229.601(b)(5), in connection with the Registration Statement.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">For purposes of this opinion letter, I, or other attorneys in the legal department of the Company under my direction, have examined copies of such agreements, instruments and documents as I have deemed an appropriate basis on which to render the opinions hereinafter expressed.  In my examination of the aforesaid documents, I have assumed the genuineness of all signatures, the legal capacity of all natural persons, the accuracy and completeness of all documents submitted to me, the authenticity of all original documents, and the conformity to authentic original documents of all documents submitted to me as copies (including pdfs).  As to all matters of fact, I have relied on the representations and statements of fact made in the documents so reviewed, and I have not independently established the facts so relied on.  This opinion letter is given, and all statements herein are made, in the context of the foregoing. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">This opinion letter is based as to matters of law solely on the Delaware General Corporation Law and the Minnesota Business Corporation Act. I express no opinion herein as to any other statutes, rules or regulations.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">Based upon, subject to and limited by the foregoing, I am of the opinion that following (i) effectiveness of the Registration Statement, (ii) issuance of the Shares pursuant to the terms of the Plan, and (iii) receipt by the Company of the consideration for the Shares specified in the applicable resolutions of the Board of Directors and in the Plan,  the Shares that constitute original issuances by the Company will be validly issued, fully paid, and nonassessable. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">This opinion letter has been prepared for use in connection with the Registration Statement.  I assume no obligation to advise of any changes in the foregoing subsequent to the effective date of the Registration Statement.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">I hereby consent to the filing of this opinion letter as Exhibit 5.1 to the Registration Statement.  In giving this consent, I do not thereby admit that I am an &#8220;expert&#8221; within the meaning of the Act. </font></div><div style="margin-top:9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">Very truly yours,</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:36.057%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">&#47;s&#47; Faraz A. Choudhry</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">Faraz A. Choudhry,</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">Senior Associate General Counsel</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.2
<SEQUENCE>4
<FILENAME>exhibit232espp.htm
<DESCRIPTION>EX-23.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i63145890cbbb498f8569a169913923f3_33"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Exhibit 23.2</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We consent to the incorporation by reference in this Registration Statement on Form S-8 of our reports dated March 1, 2021, relating to the financial statements and financial statement schedule of UnitedHealth Group Incorporated and the effectiveness of UnitedHealth Group Incorporated&#8217;s internal control over financial reporting, appearing in the Annual Report on Form 10-K of UnitedHealth Group Incorporated for the year ended December 31, 2020.</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#47;s&#47; Deloitte &#38; Touche, LLP</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Minneapolis, MN</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">October 29, 2021</font></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-24.1
<SEQUENCE>5
<FILENAME>exhibit241espp.htm
<DESCRIPTION>EX-24.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="ie9f9309010584296846ddecbe1a9a62a_33"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Exhibit 24.1</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">POWER OF ATTORNEY</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Matthew W. Friedrich, Dannette L. Smith, Kuai H. Leong and Faraz A. Choudhry, and each of them, his or her true and lawful attorneys-in-fact and agents, each acting alone, with full power of substitution and resubstitution, to sign, execute and file with the Securities and Exchange Commission (or any other governmental or regulatory authority), for us and in our names in the capacities indicated below, a registration statement on Form S-8, and any and all amendments (including post-effective amendments) thereto, relating to the UnitedHealth Group Employee Stock Purchase Plan, with all exhibits and any and all documents required to be filed with respect thereto, granting unto said attorneys-in-fact and agents and each of them, full power and authority to do and to perform each and every act and thing necessary or desirable to be done in and about the premises in order to effectuate the same as fully to all intents and purposes as he or she might or could do if personally present, hereby ratifying and confirming all that said attorneys-in-fact and agents, or any of them, may lawfully do or cause to be done by virtue hereof. </font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">IN WITNESS WHEREOF, the undersigned have executed this Power of Attorney as of the date set forth below. </font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.919%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.703%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.078%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#47;s&#47; Richard T. Burke</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#47;s&#47; F. William McNabb III</font></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Richard T. Burke</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">F. William McNabb III</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Director</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Director</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Dated&#58; October 29, 2021</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Dated&#58; October 29, 2021</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#47;s&#47; Timothy P. Flynn</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#47;s&#47; Valerie C. Montgomery Rice, M.D.</font></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Timothy P. Flynn</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Valerie C. Montgomery Rice, M.D.</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Director</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Director</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Dated&#58; October 29, 2021</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Dated&#58; October 29, 2021</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#47;s&#47; Stephen J. Hemsley</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#47;s&#47; John H. Noseworthy, M.D.</font></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Stephen J. Hemsley</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">John H. Noseworthy, M.D.</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Director</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Director</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Dated&#58; October 29, 2021</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Dated&#58; October 29, 2021</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#47;s&#47; Michele J. Hooper</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#47;s&#47; Gail R. Wilensky, Ph.D.</font></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #3b547b;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Michele J. Hooper</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Gail R. Wilensky, Ph.D.</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Director</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Director</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Dated&#58; October 29, 2021</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Dated&#58; October 29, 2021</font></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>uhglogoa06.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 uhglogoa06.jpg
M_]C_X  02D9)1@ ! @$!+ $L  #_[0 L4&AO=&]S:&]P(#,N,  X0DE- ^T
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M P,# P,# P,# P/_P  1" "& O@# 1$  A$! Q$!_\0!H@    8" P$
M        !P@&!00) PH" 0 + 0  !@,! 0$            &!00#!P(( 0D
M"@L0  (! P0! P," P,# @8)=0$" P01!1(&(0<3(@ (,11!,B,5"5%"%F$D
M,Q=2<8$88I$E0Z&Q\"8T<@H9P=$U)^%3-H+QDJ)$5'-%1C='8RA55E<:LL+2
MXO)D@W23A&6CL\/3XRDX9O-U*CDZ2$E*6%E:9VAI:G9W>'EZA8:'B(F*E)66
MEYB9FJ2EIJ>HJ:JTM;:WN+FZQ,7&Q\C)RM35UM?8V=KDY>;GZ.GJ]/7V]_CY
M^A$  @$# @0$ P4$! 0&!@5M 0(#$00A$@4Q!@ B$T%1!S)A%'$(0H$CD152
MH6(6,PFQ),'10W+P%^&"-"624QAC1/&BLB8U&50V160G"G.#DT9TPM+B\E5E
M=58WA(6CL\/3X_,I&I2DM,34Y/25I;7%U>7U*$=79CAVAI:FML;6YO9G=X>7
MI[?'U^?W2%AH>(B8J+C(V.CX.4E9:7F)F:FYR=GI^2HZ2EIJ>HJ:JKK*VNKZ
M_]H # ,!  (1 Q$ /P#?X]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=:KO\[S^=U\FO@#\F]E_'
MGX[[.ZIDI'ZFPG8^[=T]D8'.[GKLED=T[@W/B<=AL+08G<^W*3%XW$4.V?++
M-+]Q-53U6D"%(+SSO[8^V.R<V[)+O&\27&KZAHT6-E4 *JDLQ*L226H *  >
M9.(/]RO<G>N5=ZCVG:(X-/@+(S2*S$EF8  !E  "U)-22?*F3V_R.OYE?;/\
MR7H/M#=?=NU=EX#L'JCL>FVE4Y38%'D\3MW<>$SF"@SF(JFPF7RV=JL;EZ"0
M5$%04JF@F01.J(VL$*^Z')6W\E[M!;[9)*]G<0EP)""RLK:2-0"@@X(Q49XX
MZ%'MISE?\X[5//N4<:7<$P4E 0K!EU T)8@C(.:''#/5VON,NI(Z)[\__DWD
MOAO\-N__ )+X3 8_=&?ZJV0<KMS!9AJI<-7[ER^8Q6U]N#-"AJ*.NEPM/F\Y
M!+61P30324T;I')&Y#J(N4MD3F/F.TV25S'%<2T9A2H4 LVFM1JTJ0*@@&E0
M>'0?YJWI^7N7KO>8D#RP15536A8D*M:4-*L":$&E:$=:MW\M3_A1!\T?DI\U
M^BOCYW9LKHO*; [AW/-LO(5.S-J[GVGN?!5M9B<C58K-XW)5>\]PX^=*+(4D
M?W%-/1N*BG9T1X9"LJSKSK[/\M;+RS=;OMDMTMW;1ZP'975@" 5("*<@X(.#
M3!&.H2Y-]VN8]YYDM=IW*.U:UN'T$HK*RD@D$$NPP1D$9'F#GK=3]XT=9&]>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW6C%\@?^%2?S"V3W[VELWK3H?XU4_6FRNQ]S[2P=)OK#=HY_?5=A
MMK[@K,*:O+;BP':FU<!%D\M%0F8+#B3%2-($_P H":WRDVCV*Y=N=I@N;V[O
M3>RPJ[%#$J!F4-0*T3-05IEZFE<5H,9MU][>8+;=9[>SM;,64<S*H<2,Y"L1
M4LLJK4TKA:#AFE3N0?%;O&'Y,_&OHGY!P8&7:R]S=4['[&EVW+5)7G U>ZL!
M0Y6NQ$=>B1"OI\?65$D44YCB::)5=HXV8HN.._;6=DWJZV@OXGTUP\>JE-05
MB :>51DC-#BIX]9";'N8WG9K7=@NCZB!)--:Z2R@D5\Z' .*C-!PZ'WV4]&O
M5+W\[#^9MV1_+-Z,ZOWKU%L'9&^-_=I]B5FT:!^QTSU7L_ XK#;>JLUE*ZKQ
M.V<[MG-97(5,S4T5/&E?31HIE=V8JJ-)7MGR19<[;I/;;A++%:00ASX>D.Q+
M!0 65E XD]I/#J.O<CG.\Y,VR"YL(HI;J>8H/$U%% 4DDA64D\ .X>?1.OY)
M7\[CO_\ F0]_]F="][]6=/;7J]K]/9?M[;VZ^I*/>N I_M\!O7K_ &97;>S.
M"WCO+?LE;-6R;]2IBJX*RE6):5HVA<N'41^YOMCM/)FTP;MM4]S(LER(624H
MWQ)(X961(Z4\.A!!K6M12G0>]MO<G=><-UFVO=(+=&2W,JM$'7X7C0J5=WK7
M74$$4I2AK7K9F]PEU,W7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=4:_S*?Y\'Q>_E^YO*=3
M87%U_P @?D7CZ<-DNMMHYBCP^VMBU$\,4]'3]F;ZEILI'@LE403"9<;0T61R
M*QZ341TJ2PRO*/)7M5OG-T2[A*PM-F)Q(X)9_7PTJ-0\M3,J^A8@@1GSC[H;
M)RI*UA&IN]W S&A 5/3Q'SI/GI4,WJ%!!ZU>NU/^%/'\RC?&1J)=AOTCTMB?
M/(:&AVCUM'NG()2G4(H\CE.RLIO*GK:I 07EAI*1'87$:CT^YRL/8_DNU0"[
M^JN9*9+R:17Y",)0?(D_;U"E][T\XW+DVOTUM'7 2/4:?,R%ZGY@#[.@0P7_
M  HH_FX8BK^XR'R5PFZ(=41^PSO170E/26CD#NNO;/6NW:[34*-#_O7"GTE6
MLWLTE]G?;Z1:)9-&?59YZ_\ &I&'\NBV+W;Y]C:KWBN/1H8*?\9C4_SZLA^-
M7_"KKO';^1Q^*^6'Q]V#V/MHN(*S=O3-3E.O][4=.=+'(3[<W+E-T;4W/6JP
M9?!#/@(F5E.L%&\H,WKV#VN9#)L%Y+#/Y),!(A^6I0KJ/F1(?EG PV;WTW.)
MQ'OMI%-#YO"3&X^>EBRL?D"@^>,[Q>&RM-G,1BLW1"44>8QM#E:03H(YA39"
MEBJX!,BLZI*(IAJ 8@'\GWB])&T4C1-\2L0?M!IUDM&ZRQK(OPL 1]A%>G+W
M3J_7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U R>4QF%H:C*9G(T&)QM(J-59')U=
M/04-,LDB0HU15U4D5/"KRR*H+,+LP'U(]W2-Y6"1@LYX "I/Y#JKND:EY"%0
M<230#\ST&V+[ZZ,SE;%C<+W/U/F,C4:O!C\7V+M#(5LVA2[^*EI,Q-/)H0$F
MRFP%_:V3:=TB4O+;7"H/,QN!^TCI&FZ;9*VB.Y@9SY"1"?V ]"Q[+^EW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]TQ
M[BW-MO:&*J,]NS<&#VO@Z1HEJLSN++4&$Q5,T\BQ0K49')5%-1PM-*P50SC4
MQ '/MV&":XD$5NC22G@J@L3^0J>FIIH;>,RSNJ1#B6( _::#K/@\[@]S8JBS
MVV\SBMP8/)1&?'9G!Y&DRV*KX1(\1FHLC035%'51"6-E+1NPU*1]0?>I8I8)
M#%,K)*O$,""/M!R.K12Q31B6%E>(\"I!!^PC!Z=?;?5^O>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z^>#_ ,*C/^WE6"_\5DZM_P#>L[,]Y@>Q?_*E
M/_SW2_\ '(NL2_>S_E<5_P">*+_CTG5M/_"2[_LGCY;?^)GV1_[P\_N/_O ?
M\EC;_P#GF?\ X_T//8?_ ))-_P#\]*?\<ZVU?>/_ %/'52G\];_MTY\R/_#,
MV3_[]SKWW('M9_RO^V_\U7_ZM2= /W._Y43<?^::?]78^M"G^3/_ -O1OA1_
MXFC%_P#NHS'O*[W(_P"5%W/_ )YC_A'6+GMW_P KMMO_ #TC_ >OJ@^\$>LW
M^OFI?SQ_D+WWB_YI7RMV]B>Z^U\/M_;.X=D87;N"P_86Z\3A<'B8^KMD5PQ^
M)Q6.RU-04%*U=73SNL4:AYYY)&N[LQS4]KMHVF3D2PFDMK=IG1V9C&A9CXKB
MI)!)- !GR ' =8<^YF[;HG.]]#'<SK$CH%42, H\-#0 $ "I)QYDGSZ2'\I+
M^9YW!\4OFKU-G>T^Z.Q=P="[^S]'UUW+@MX[]W'F]L46V]UR?P>@W]4T&;R5
M?0TM7UQF:R#+-51Q&J^P@JJ:-@M2X*CW!Y'V[?\ EFXBL+:%-VB0R0LD:JQ9
M,F,%0"1( 4I6FHJQ^$=)^0N==PV+F."6^N9GVN5Q',KNS*%; >A) ,9(:M*Z
M0P'$]?3:5E=5=&5T=0RLI#*RL+JRL+@J0;@CWA'PZS.XY'6KA_PJ;[<[1ZT^
M-'QJQ?7786\-AT>[.ZL\^Y1L[<&3VU4YQ,!LJIEQ%+DJ_#5%'7U./HZC)2S"
MF:7[=YQ'*Z-)#"R3I[$[?8WN]WLEY#'*T=LNG6H8+J?) -0": 5I6E16A-82
M][[^]L]FLTM)9(EDN6U:&*ZM*8!(H2!4FG"M#2H%$7_PE4[=[4[)ZI^8&'[$
M[&WOOS&[5W[U-6;:I=X[GS.YEP51N3 [W3/-BI,S65LM$F5& HS,D;*C- K6
MU7)5>_.WV%E?[=)9PQ1/)%*&**%U:6336@%::C3[>D_L=?WUY8[A'=S2RHDL
M14.Q;3J5]5*DTKI%?LZVQ?< ]3KU\CGN'Y6?)K</;W9VXLI\@NYYLMENP]X9
M2LJ(NS=YTJ_=U.XLA.YIX*;-104<,3M:**)4CB0!4"JH Z#;=L.R0[=!#':6
MPC6% !X:' 4>JY^9/'SZP*W#?-ZEW">9[NY\1IG)_4<9+'YX^5.'7U&?@?NW
M<N_O@[\--][SS5?N3>&]?BE\=]V[KW%E)C49//;EW'U#L_,9W-9&<@&>ORF4
MK)9YGL-4DA/Y]X,<U6\%IS1N5K;*$MHK^X1%'!569PJCY   =9L<KSS77+.W
M75PQ>XDL;=F8\69HD+$_,DDGKY^?>GPR_G?_ .FCM:3)]7_.3<U=5=A;NKJC
M<.ULIV1NC;F;:OSE;6KE,)GMLY6LP.2QM;'4"2)Z60Q*K!0%*E5RWVKF3VP_
M=MN$GVM$$*#2PC5EHH%&5@&!'G7/6*FY\N^Y7[QG+P;F[&5SJ4R,IJQ-0RDJ
M0?*F.B4]ZX#^8Y\8O[K?[,//\M>E_P"^_P#&_P"Z'^D?<?9VU?[R?W:_A']X
M/X-_%<I3_?\ \'_C]%]QX[^+[J+5;6+B;:IN3=\\3]S_ +ON?"TZ_#6)M.JN
MFM!BNEJ>M#T&]SBYOV71^]C?VWBZM'B-(NK3352IS34*^E1TS=(M\_\ Y*;@
MRVU.@,Y\INXMRX+#G<.9P?7F[.RMSY/%X-:VDQIRU;28S*SRT] *^NAA\C +
MY)56]R/;FY_U2V6%;C=UL+:%VTAI$C4%J$T!(XT!-/ETWMO]:MYE:#:FOKB9
M5U%8VD8A:@5(!X5('Y]&PP'PQ_GAOG,.N&Z@^?N-R_\ $Z$XO(5-7VO@8*'(
MK4Q-15DN;RF7H,=B$IJ@*YJ9YX8H=.MG4 D$$W,OM?X3>+<[2T>DU $35%,C
M2 2:CR )/IT>Q<N^Y?BKX=ONHDU"AK*M#7!J2 /M) '7TB.T\CNC:OQM['RY
MR=11[TVYT?N_(G,TDX^ZI=T8?861J3DZ6I10/N(,M3^5' 'J ('O#*P2"?>H
M8](-L]T@H>!4R 4/Y8ZS OGG@V>:341<I;.:CB&"$U!^W/7R9)_DM\C:F::I
MJ>_^[*BHJ)9)YYY^U=]2S3S2N9)9II9,\SRRRNQ9F8DL3<^\_ALNS* JVEL%
M'_"D_P"@>L$3O.[L:F[N23_PU_\ H+JS'_AO;^>;_P ^A^9__H>[A_\ LT]@
MG^M_M=_RD;;_ +PO_0'0S_JG[F?\H^X_[VW_ $'U[_AO;^>;_P ^A^9__H>[
MA_\ LT]^_K?[7?\ *1MO^\+_ - =>_JG[F?\H^X_[VW_ $'UN>?R(NG?F)TA
M\':G:/S4&]Z/L.M[HWSN#8^ [$W+_>?=FV>KJ[!;+H\9B<C4-D<K4XY*G>>-
MSM?#233M)'#6J]D614&-GNKN/+FZ<T"XY:\(V8MD5VC72C2AG)(P :(44D"E
M5^761/MAM_,&V\M&WYC\479N79%D;4RQE4 !R:=X=@">!^?6O+_PJ/[Q[FV5
M\YND]D[,[7[%VAM&E^)^U=TP[<VKO/<.W<0NX]P]O]T8G-YMJ+#Y"CAER63Q
MFT\;!+*X9FBHHEO91[F#V+VO;;GE:ZNKFWADN#N#+J9%8Z5AA*K4@X!=B!ZL
M>HF][=SW&VYFMK:VGFCMQ8*VE791J:68$T!&2%4$^@'5;7PB^$?\TC^8+L#=
MG9?QS[?W5D]K[+W@VQLY+NSY%;JVM6QY]<+B\^8Z:CJLG.]12_P[,0GR @:R
M5_'L:<S\S\B\HW<=EO-O&L\L>M=%NK#3J*Y('&H..@?RURWSOS7:R7FT7#M!
M')H;5<,IU4#<">%".C*;_P#Y,/\ /=V+AJK-TE7OWL""BI9:NJHM@?*>')YE
M8H;F1*7#YK>NW\CE:K0+K!1QU$TGZ41F]/LDM/<GVKNI!$PBA)- 9+6@_,A&
M 'S- //HXN_;KW/M8S(IEE %2([FI_(%U)/R%3Z=%F^//\Y+^9]\$NRZG:^\
M.T^S-^4FT\W_  ??W0_RCEW-NR:EDQU24R.WY)MZR-V'UYE:<,ZJ*&KI!'*5
M,T$Z+XR=[Q[<<C\U60GMH((FD6L<]KI2M1ANS].0'^D#4<"#GHFVGW#YUY8O
M3!<3S2K&U'@N=34IQ7O_ %(S_I2,\0>'6_W_ "]OGST__,4^/>%[QZK,N&R=
M/4#;O9?7.3K*>JW#UKOJFI8*BOP&0EA6%<EBJJ*9:G%Y)(HH\A1.KF.&=9Z:
M#$OF_E/<>3MW;:[_ +D(U1R 461*X8>A'!EJ2K>9%&.5/*?-.W\W;2NYV/:X
M.F2,FK1O3*GU!XJU!J'D#4 \_L+=";KX]_R/_P"RA^^?_$S]H_\ O<9SWT3V
M;_DCVG_/-%_QQ>N?V\?\E:Z_YZ9/^/MU]0W^5'_V[5^#7_BLG4O_ +R>/]X-
M<^_\KKNG_/=+_P ?/6:W(O\ RIVV?\\47_'1U8'["/0KZU*O^%:/_9/'Q)_\
M3/O?_P!X>#WD!]W_ /Y+&X?\\R?\?Z@?WX_Y)-A_STO_ ,<ZK*_X2E?]O#NY
M?_%,.P__ '^'QU]C?W[_ .5/MO\ I91_]6+CH%^QG_*VW'_2ND_ZO6_7T"O>
M)'65G7R <S\IODSN#+Y7/9GY"]V9#,9O)5V7RU?/VCO;SUV2R55+6UU9-HS:
M)Y:FJF=VL +MP/?1"/8MDAC6**SMA&J@ >$F !0#X?(=8 R;YO,LC2R7=R9&
M))/B/DDU)X^O5B&$^!_\[C<F&Q&XL'U?\R,GA,]C*#-8?)4V_MQM3Y#%Y2DB
MKL?6T[-O-6,-723I(A(!TL./8/EYJ]L896AEGVU948J08UJ"#0CX/(]"V/E?
MW)FC6:*#<6C900=;9!%0?C\QTZ?\-[?SS?\ GT/S/_\ 0]W#_P#9I[;_ *W^
MUW_*1MO^\+_T!U?^J?N9_P H^X_[VW_0?6W-_P )]NB_G'T5\;>W</\ ->C[
M)P=?G^V8\MUAMGM3>#;JW-C,!#MNAH=P5T%--F<Y5[<P^6S<(\-+-+"TLL$M
M0L"I,LT^/GNYNO*^Z[U;R<LF%D2WI*T2:5+:B5%:*&(7B0#0$+6HH)[]J=LY
MFVS9[B/F03*[SUC65]3!=(#'BQ4%N )%2":4-3?I[B;J4^JW/YN'RLK/AM_+
M\^0_<6W\R^#[ GVJO7G5E=2RM#DZ3L3LBICVG@\SAG!51E-GT^1J,ZFHZ0N+
M8D-;0PT]OMA7F/FZSVZ9=5H)/$E!X&.,:V!^3T"?[;H'\^[ZW+W*EWN$3:;L
MIX<1\Q)(=*D?-*E_]KU\QB3Y'_(^H\U9+WSW;-JF'W%5)VCON3545/EE'FG;
M.&\T_B=AJ.IM+'FQ]YO#9MF%%%I:C'#PDX#_ &O6%YWC>#W&ZN>/'Q'_ .@N
MMZK_ (3*?-+=_P B/BWVCT;VIOC.[X[$^.V]\;/@\ONS.5F<W!4=2]AX^>?;
M..:ORT]3E,E#MC=&W,S3AVED2DHZBCIP(T6(-BS[W<M6^S[[!NEA$D5G>1'4
M$4*OBQGN-!0#4K(>&2&.37K)OV8YCN-WV2?;+Z5I;NTE&DLQ9O"D':*G)TLK
MCC@%1@4ZV8/<)]3+U7E_-DWQO#K?^6]\QMY["W'E]H[MQ'2NXTP^Y<!62X[-
MXA\I)1X>KJL3DJ<I5XS(?89"58JF!HZBG=A)$Z2*KJ,.0+6WO><]MMKM%DMV
MN5JK"JFE2 1P(J!4'!X$$8Z"7/=S<6?)^X7%J[1SK;-1E-&%: D'B#0FA&1Q
M!!Z^=%\&_D[\C\?\T?B9/3=]]Q7F^2'2N/J8:CLG=];1UV-RW8NW<5E\7D:"
MMR]10Y+%9?%UDU+5TL\<E/4TTSQ2H\;LIS%YIV/9GY:W -:6V+*8C]- 01&Q
M!! J"" 01D$ C/6(W+.];PG,=@1=7'^YD(/ZCD$&100030@@D$'!!(..OJU>
M\"NLYNB'?S/-G]\[_P#@/\G=F_&3^\K=W[@Z]%#LJ#9N7."W37+_ !_"3;FQ
M>!R:U5%)!DLKL^+(4T:1RQRSF7Q(=;K[%?(]SM5IS98W.]Z/W6DU7UC4H[6T
MEA0X#Z3PH*5/#H+\Z6^Z77*U[;[+K_>3Q430=+'N&H*:C)34.-36@Z^?%_LF
M?\[#_GR?\P/_ ,Y.Y?\ ZK]Y=?UD]L_^4K:/VP_YNL4?ZN^Y'_*-NO[)O\_1
M5>YLQ\[?CMN^/8'>NZOD[U+O:;#T6X(MK;]WCV/MO.28/(SUE-095,=DLO!4
M-05=1CYTCDTZ6:)@#P?9]ML?*N\6_P!7M4=C<6P8KJC2-EU"A(J!Q%1CY]$6
MXR<S[1<?2[G)>P7.D-I=Y%;2:@&A/ T/[.A!Z1V!_,W^2FW\MNKH"@^8G<6V
M\#F#M_,YSKS-=I[GQF+S@HJ7)'%5M7C,E/#3UXH*Z&;QL0WCE5K6(]I-SN^2
M-EF6WW<[=;3.NH+(L2DK4BH!'"H(K\NE>VVO.F\Q-/M0W"XA5M):,RL U :$
M@\:$'\^CC= ?#;^>#%WEU#/B>M/F_M+(4O8^SJV#<^\,AV3MW:F ^RSU#5S9
M7<>8W+7QX&DPM%!"SU(JM<4L0:,QR:A&P<W;F3VP.UW DGVN1#"XTH(V9JJ1
M10HU%CY4R#FHX]"':N7?<L;G;E(=RC83(=3F156C U8L=( \ZXIBAX=?0"^>
M6Z]R;#^#?S-WQLW-9#;6[]F?%#Y$[KVKN+$5#TF5P&Y-N]0;PR^#S6,JH[24
MV0Q63HXIX9%Y22,$?3WB3RI;PW?-&VVMRH>WDO[='4Y#*TR!E(\P02#\NLJN
M:)YK7EG<;FW8I<1V-PRL,%66)RI!\B" 1U\Q+XQ_*#Y)X_Y*= Y&E[_[G6KB
M[JZQ?7+V;O.JCF$N]L*E1#5T]5F9J>MI:N*1HYX9D>*>-V2161F!S?WO8]E?
M9;M&M+;3]-+_ *$@_ W"@J"/(C(.1UA=LN][PF\VKK=W.KZF/_1'/XQQJ<@^
M8.#P/7UG/> /6=W26WQ7U>+V5O#)T$S4U?CMK;@KZ*H549H*NCQ-744TRK(K
MQLT4T:L P(-N01[?M462YC1Q5&D4'["17IBY9DMI'0T8(Q'V@'KY%J_*OY0)
MFUW*GR-[V3<*949Q,TO;>_ER:YE:O[]<HM:,^*A:]:X>42AM8D]5[^^A'[AV
M,Q> ;.U\'3IT^%'332E*:>%,4ZP(_?F]^+XWUEUXNK57Q7K6M:UU<:YKU]=+
M8]?5Y396S\G7S-4U^1VMM^OK:AE16GJZS$TE14S,L:I&K2S2,Q"@ 7X 'OGO
M=(L=S(B"B+(P'V FG6>]LS/;1NYJQ12?M('2I]L=/]56_P Y+YU5WP!^#V^^
MU-HST\7;F^,E0]1],M41QU$>/WUNZARE5+NB2FD)64;+VMA\CE81)'+3RUU+
M303*8YB/8\]N.5DYMYHBL+@']WQ*99OFB$#37^FQ53P(4L1D= ?W#YG;E7EJ
M6^MR/KY6$4/R=P3JI_04,P\BP .#U\R79&S^Q_D)V]MG8^VXLKOGM;N7?^-P
M&+%;53UV7W/O;?.=CI4JLGD:IIIYJC(Y?(F:JJIF-M3RR-8,?>;EU<V6T;<]
MU-IBL+:$L:"@5$6M !Z 4 'R ZPQMK>\W;<$MH=4M]<2A14U+.[4J3\R:DG[
M3U]+;^75_)M^)WP.ZVVU#4]?;)[?^0+T%-5;[[SWKMC'Y[,SY^5#)6T77U/G
MH*]=A;3HI)#!3Q4*P555#&DE;+/-RN%/./N/O_-=ZY6:6WVBI"0(Q4:?(R::
M>(YXDM4 U"@#K,CE'V\V+E>S0-%'<;K2KS.H8ZO,1ZJZ%'  4)&6)/5FO9'4
MW5O<>WJC:7;?6^Q>SMKU<-33U&WM_P"T\%N_#20UD:Q52''9^AKZ5?/&@#$*
M"=(YX'L$66X7^VS"XV^:6"<$=T;LAQPRI!Z&=Y86.X0F"_ABF@(/:ZJXSQPP
M(ZU7?F9_PF,V1NCOWJ[LCX;9?"; ZFS?8NVSWETYO/*Y7(8_:FTGS=#-N/<7
M5.0K8\I6Y*G;%BHUX#(U*JDA44M2L)%-#/'+?O?=0;3/9<R*TVX+"W@3( "[
MZ3I64"@&:?J*/],M>XP?S%[+VT^ZP7G+S+%8-,OC0N20JU&IHB:DXKV,?]*:
M=HVX_>/G4]]?/E_X4D]]=W[9_F2Y/:.V>W^S-L;6V_TMU<,-MS;6^-R;?PF/
M?*T^7RF3G@QF'R5%1_=U]=4L\TS(9I $5F*QHJY=>R^T[7/R6MQ/;P/.]S+J
M9D5F-" ,D$T &!P_:>L4?>'=-RAYQ:WAN)D@2VCHJNR@5J3@$"I/$\?V#HGG
MPB^$?\TC^8+L#=G9?QS[?W5D]K[+W@VQLY+NSY%;JVM6QY]<+B\^8Z:CJLG.
M]12_P[,0GR @:R5_'L1\S\S\B\HW<=EO-O&L\L>M=%NK#3J*Y('&H..@_P M
M<M\[\UVLEYM%P[01R:&U7#*=5 W GA0CH9>Y?Y5W\]/XZ;;RO959)W9NK!;1
MIVRF1S/3?R-R6],_C*2&G,U3D*/:V$WE!OVLBHH]7F>CQTQB56=K1C7[+=MY
M\]K-YF6R7Z6.60T"S6X12?0LR>&*^56%>'''1AN/(_N;M$+7C?4O%&*DPW!=
M@/4*'UFGG133CPZ7O\M7_A0W\IOCOV/M/8_RV[!W)\B/CGF<G0XG<V:WQ++N
M3MSKNCJVCI'W?@-\5&O<F[X<62E16XW,39!JJ")UI9*:=R[I.=?:#8MXLY+K
ME^%+/>54E53MBD(SH9!VI7@&0+0GN# 4"KDWW9WS:+R.VWZ5[O:&8!B_=+&#
MC6K_ !/3B5<M4#M()J?H78W)8_,XZ@R^)K:7)8K*T5+DL9D:&>.IHJ_'UT$=
M51UM)4PL\512U5-*LD;J2KHP(-C[Q!='C<QR K(I((."",$$>H/662.DB"2,
M@HP!!' @Y!'R/5$O\[+^<31?RX]EX/JSJ*DP^Z/E9VE@Y\UMNES,:5VW>J]E
M"MEQ@[!W5BQ-%+EJ_+U])54N"Q]Q!/44=145+>&F6FK)4]LO;IN<KEK_ ' M
M'L$#:6(PTKTKX:GR !!=N(! 7+:EC#W(]P5Y0MEL=O"OOLZU4'*Q)6GB,/,D
M@A%X$@EL"C:8_1O0O\R+^=;W9GHZ;>F[^Y,Q@UCRV]>SNX]YY6AZJZQILF]0
MF-II)(:3(X[;JY*9)4H,)M[%2U#1I+)#1BG@J)(LDMTW;DSVSVQ"T4=M&^$B
MA0&64CB>(+4QJ>1@*T!:I ..^V;7SA[C[DP$DEQ(N7DE<B*,'@.!"USI2-2>
M)"T!(LTWS_PE,^:N!VC+F=E=X_'K?VZJ6EFJ)]F&KWQM4U\D2ADH<#N'*[8G
MQE56U!N$->N,IP;:Y5'(!-K[]<LRW'AW-K>10$TUT1J?-E#5 _TNH_+H9W7L
M9S'%;^);7-I+.!\%76OR5BM"?]-I'SZK?^.?\Q#^8Q_*>[KR?5U;N3>^,I^N
M-P)@NR?B]W)69'.[%>.G6.6;'4.*K*NJ.T)J^@J(JFBS&WIZ854+03"2KHV$
M<HRWGD_DWG_;%OE2)C,FJ.YA 5_M) &NAJ&20&AJ**V0#]HYMYNY$W)K)GE4
M0OIDMIB63[ "3HJ*$/&144-67!^BW\)?F%U;\Z_CAL'Y&]3SM#A]V4CT>XML
M557#5YK8&^,6L46Z-B[@:%(1_$L'62@QRF.):VBEIZN-1#41DX=<S\NWW*N\
MS;-N K)&:JP%%D0_"Z_)AY5.E@5.0>LN>6^8++F?9XMWL32.0492:E''Q(WS
M4^>*@AA@CJMO_A1=V)OSK7^63OO+]>;RW+L?+Y7M#JC;]?F-IYFOP&7GPE;N
M"2KK<8,IBYZ:OAI*V;'Q"9(Y%$T:F-[QLRL-/9RSM+WG>*.\C26-8)6 <!AJ
M"T!H:BHJ:>G$9Z!WNY=W5GR9+):2/%(T\2DJ2IH6J144-#05]>'#K57_ ) /
MR![VSO\ ->^,^TL[W/VIG=K;NQ_>&*W/MS.;_P!U9C"9['8[H#M#=5!1Y7%Y
M+*U5%604>Y-NT%=$'0Z*FDBD%F0'W/'NUM&U1<@WMQ%;0)/&8"K+&H929XE)
M! !%59E/R)'4'^U6Z[I+SU902W,[02"8,K.Q5@()& ()(-&56'S /7T?/>&G
M67W57?\ .FWKN_KW^5Y\OMV;$W/G=G;HH-A8"BH=Q;:RE9A<W0TV>[$V;M_,
M1463Q\T%92?Q'"Y2HII#&ZL89F6_/L<^VEM;WG/.W6]TB20&5B58!E)6-V%0
M<&C $?,= GW&N;BTY*W">U=HYQ$H#*2"-4B*:$9%02/L/6F9_P )_OD/WUF?
MYK7QLV;F^Z.TL]M/>N-[MQ&Z]MY[?FYLW@\_CL7T'V?NW&TV2QF5R=71SK0[
MEVW0UL3%-:3TR$$<@Y(^[>S[5'R%>W,5M EQ$T)1EC564F>)"00 <JS _(GK
M'?VJW;=).>;.WEN9V@D$P96=F5@()'%021AE4CYCK?U^6FX\[L_XJ_)G=NU\
MK6X+<VUOC[W-N/;N<QLS4V1PV=PG7.Y,GB,K05">N"MQV0I8YHG'*R("/I[Q
M,Y?ABN-^L;>=0\$EY"K*<@JTB@@_(@T/65._32V^QWL\#%9DM)F5AQ#"-B"/
MF"*CKY2>U>Z_D[OC=FV]H8;OCN*;.[OW%A]MXH5?;&]X(9<MN#)4^,H14U+Y
MQA#%)65::Y#?2"2?>>T^V;':V[W$EI;"*-"QI$G!14T&GT'6#$&Y;U<SI;QW
M5P99'"BLK\6-!4ZO4]7O3_R+_P">A%#-+'V/+4O%%)(E-!\LLTLU0Z(66"%J
MG)T].LLI&E3)(B GU,HN1%0]TO:TD PT'K]*/\@ZE ^V7N:!435/_/4?\_5>
M/:^X/YNG\KGMC$8_LOLSY,=#[SR4$N1P%7/VEE=W;!WUC\?4I'.U+5TNX=U]
M:;]HJ*9HFJ:*?[LTIEB^X@C9T!&%A%[>\];>SV4%E=VRFC#P@DB$CS!5)(R<
MT84K0T)H>@E?2\_<DWRI>37MK<$54^*71P#Y$,T;@8J#6E14"HZW.?Y'O\W6
MK_F/==[KZZ[CI,+@_E!TYC\=D=S-@:88_!]G;$JY(,72]C8G%!V3#9>CS3K2
M9RAA HX:BII9Z;1%5_:4F-ONA[>KR9>1WFW%FV.Y)"ZC5HG&3&3^(%<HQR0&
M#5*ZFR)]M.?FYOM)+3< J[W;@%M(HLB' D \B#AU& 2I6@;2I*_GMGMV=O=B
M=O=N[A@W5O7-]5?S-.E_@;T_U!B.MNE>ZZ[9?559T9A.PNP=U]6=/?(G!9OI
MC,=U]V;GWH&I,]FZ+[RGH\524-'6P4WW G$O*D-OMUG;[?"8XHKC9)KZ:8R3
M0AY1.T<:2S6[+,(853*(U"69V4M2@<YIEGW"[N+^8/)+!O,-E%$(X9BD1A62
M1HHKA6A,TS/AW%0%558+6KK_ "I,[VMUUOSX4=EO48/";5_F$;I^7FU=T]=;
M1VOUUL+;>Y-F=+;0R'8?4/R$W+U)TY+3]4]3=[45?M7);6W9%@:6FIZN/)T4
M>2A7*0%RWS[%87EKN=D S3[1':,LCM)(RO,XCFMUEF_5E@(998C(2058H?#/
M5^19;ZTNMMO:JL&[/=*T:+&BLD*&2*=HHOTHIP5:*4( #J4.-8ZVI/<$=3AU
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7SP?^%1G_ &\JP7_BLG5O
M_O6=F>\P/8O_ )4I_P#GNE_XY%UB7[V?\KBO_/%%_P >DZMI_P"$EW_9/'RV
M_P#$S[(_]X>?W'_W@/\ DL;?_P \S_\ '^AY[#_\DF__ .>E/^.=;:OO'_J>
M.JE/YZW_ &Z<^9'_ (9FR?\ W[G7ON0/:S_E?]M_YJO_ -6I.@'[G?\ *B;C
M_P TT_ZNQ]:%/\F?_MZ-\*/_ !-&+_\ =1F/>5WN1_RHNY_\\Q_PCK%SV[_Y
M7;;?^>D?X#U]4'W@CUF_U\O+^>K_ -O8OF3_ .'ILO\ ]]+U][SE]K/^5 VW
M_FD__5V3K"GW._Y7O<?^:B?]6H^I7\V;X7#XT9WXJ=R;6Q!H>L?EI\5>E.S*
M%X(63'T/:>.ZRV51=MXB)Q"B?<9#*5M'N"2[N3)G7 LJ!17V_P"9?WW%?[;.
MU;[;[^:,^IB,KF(_8 #&/D@ZWSYRY^YI;'<8%I97]C#(/02B-!*/S)#_ .WZ
MW8_Y#WS7/S+^ NP!N;--E.W.@6@Z1[--95+/ELB-LXZE;8>[ZS7:KJ%W1LF2
ME6:LEU&JRM'7>MW1S[QF]U>6?ZM\V3> NG;[O]>*@P-1/B(/+M>M ."E/4=9
M(>U_,G]8N58O&;5?VOZ,E3DZ0-#GS[DI4GBP;T/597_"M'_LGCXD_P#B9][_
M /O#P>QM]W__ )+&X?\ /,G_ !_H&>_'_))L/^>E_P#CG2+_ .$C_P#S+SYO
M_P#AY]%_^Z/L_P!J?O!?[F;7_P TI_\ CT72;V%_W$W+_FI#_P =DZW"?>.W
M60/7QN^Q_P#F8>_/_#SW1_[O*[WT<LO]PXO^:2_\='7/6\_W+E_YJ-_QX]?5
MU_EP?]N\?@9_XIA\7/\ WQ^QO>!'.?\ RN&[?]+*Z_ZOOUG1R?\ \JEM?_2N
MMO\ JRG1S_8:Z$76F'_PKN_[I\?^78?_ #M7O)/[O7_+7_ZA?^UGK';W\_Y9
M/_45_P!J_19/^$GG_99GR-_\5CG_ /?J=>>SOW]_Y5NS_P">[_K%)T2^Q7_*
MQ7G_ #Q?]98^M]?WBCUE'T"_R0_[)W[Z_P#$+]I?^\/G?9GLO_)8M/\ GIB_
MX^O1=O'_ "2;K_GFE_XXW7Q\/?1+KG]U]G?WS:ZZ)=>]^Z]U[W[KW7S]?^%6
MO_;P[IK_ ,4PZ\_]_A\BO>6_L)_RI]S_ -+*3_JQ;]8I^^?_ "MMO_TKH_\
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MF"/<&=DH]P]<SQ1 @-D*W?NW*'%1-_8CRLO]3[7>\6R'>.2YIXQ6XLG6=?\
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M0+GH#R=-<W'*>VSW9)N7L82Q/$DQKD_,C)^9ZP/YNBMX.:=QAM !;K>S!0.
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M1M301CW+?LI?7%MSS%:Q$^#<P2HX\J*AD4G[&0 'B*D>9ZBKWDLH+GDJ2YD
M\:WFB9#YU9Q&0/M5R2.& ?(=:KO_  G#WEF]L?S8NCL)BC4"A[%V5W=LW<OA
MD*1G"4/4VZ^P8!5J(91+3_WCV+CR%+1CRA&U&VAIW]Y;:*?D"ZEDIKAEA=?]
M,94CQ\]+M^5>H/\ :"XD@Y[MHDKIFCF1OL$329_VR+^=.MX7Y&?R^*7M+N:@
M^1?3?9>-Z:[>.?Z_W7NZGW=UE1]S=1]A;QZEHZ[&=4]B[IZYDW=UYF:;M#K;
M$9.>@Q><Q.X,9.V.=:6M2LIX8(XL8-FYO:QVT[-N4#7.W:)$31*898TE(,L:
MR:)%,4A 9D>-AJ[E*DDG)7=^4UOMQ&[[=,+?<-<;-KC$T4CQ B*1H]<9$D8)
M57613I[6#  #/\3?Y>.V/CQVCO/Y [ZWS%VUWGO.HWK)3Y+";'H>J.HNMH.R
M<_0;I[*/4?3V/SV[8MIYCLW<6*I*S<65K<QE\IDI*6-1/%$9HY=;_P X3[Q8
MQ;1:Q?3[7$$PSF663PU*Q^+,536(E)$:JB*M3@FA&]AY2AVF^DW6ZE^HW.0O
MD((HH_$8-)X409])D8 R,79FH,@5!L8]@WH7]>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U\\'_A49_P!O*L%_XK)U;_[UG9GO,#V+_P"5*?\ Y[I?
M^.1=8E^]G_*XK_SQ1?\ 'I.K:?\ A)=_V3Q\MO\ Q,^R/_>'G]Q_]X#_ )+&
MW_\ /,__ !_H>>P__))O_P#GI3_CG6VK[Q_ZGCJI3^>M_P!NG/F1_P"&9LG_
M -^YU[[D#VL_Y7_;?^:K_P#5J3H!^YW_ "HFX_\ --/^KL?6A3_)G_[>C?"C
M_P 31B__ '49CWE=[D?\J+N?_/,?\(ZQ<]N_^5VVW_GI'^ ]?5!]X(]9O]?+
MR_GJ_P#;V+YD_P#AZ;+_ /?2]?>\Y?:S_E0-M_YI/_U=DZPI]SO^5[W'_FHG
M_5J/K;N^>'PL'S1_D;=+8?;V)&1[8Z6^+W1/=_5!A@:;(UF7V7TW@9=T;5HE
MA*3U,N\MD39"CIZ>_CDR9HY&4F);8]<J\R_U:]T;F29M.WW-]/!+Z /,VESZ
M:'TDG^'4//J?.:.7/ZQ^V=M'$M;ZVLH)HO4E(5U*/].FH ?Q:3Y=:R?_  G<
M^:S?%7YY;?ZVW/E6H^J/E;3X_I[<L514F''8WL&2N>HZ@W/)$2L<E7'N:JEP
M09V6.&EW#/*US&ON;O>'EG]_<J/>P+6_L"9EQDQT_67[-(#_ #,8'GU#'M)S
M)^X^:$LYFI8WP$3>@DK^DWVZCH^0D)\NKMO^%:/_ &3Q\2?_ !,^]_\ WAX/
M<8_=_P#^2QN'_/,G_'^I)]^/^238?\]+_P#'.D7_ ,)'_P#F7GS?_P##SZ+_
M /='V?[4_>"_W,VO_FE/_P >BZ3>PO\ N)N7_-2'_CLG6X3[QVZR!Z^-WV/_
M ,S#WY_X>>Z/_=Y7>^CEE_N'%_S27_CHZYZWG^Y<O_-1O^/'KZNO\N#_ +=X
M_ S_ ,4P^+G_ +X_8WO CG/_ )7#=O\ I977_5]^LZ.3_P#E4MK_ .E=;?\
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MD6H?Y'KZM7O KK.;KX]_R/\ ^RA^^?\ Q,_:/_O<9SWT3V;_ )(]I_SS1?\
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M$BA5'@VYH * 5,1)H!YYZ>O^@A+^;]_WEU_[ /XP_P#VE?;?^M#[=_\ 1O\
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M_P#5].@[SA_RJ6Z?]*ZY_P"K+]?)QVWN',;1W%@=U[>K/X?G]L9K%[AP=?\
M;TM7]CF,+709+&5GVM=!4T53]M6TR/XYHY(GTV=64D'/N:&.XA>WF%8G4JPR
M*AA0BHH14'R->L$X99+>9)XC25&#*<&A!J#0U!H1YXZN$_Z"$OYOW_>77_L
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M3K+3F3_E7;__ )XI_P#JTW7RB_CA_P!E#]#?^)GZN_\ >XP?O/?>?^2/=_\
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MZM+U\Y+^<[\.*WX'_P P;LO;NSJ*HVUUMV!DH>]NBZS$%\=#AMM;NRE775&
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M>FDE."S@5)]/U5&KYLKD\1U)WLQS5^\MI?EV[:MY9BL=>+0$T ]?TV.GY*R
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MB.:=S*>!!].CGVCYNY<Y>V6YM=YND@G>ZU*"KFJ^&@KVJPX@CJ\OL#_A0O\
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MX?\ 90_0W_B9^KO_ 'N,'[SNWG_DCW?_ #S2_P#'&ZP@V?\ Y*UK_P ],?\
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MGR%-'M+MW9G8.>R]-3J6E;;NU-A9;<FZ-QN" NFAHZAM;!;7(O!EGR/SA?7
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MOU_S-N\V];D5^KF(J%!"J%4*JJ"20  .)))J2223T+]@V.QY<VJ+9]N#?2Q
MT+$%F+$LS,0 "22?( "@   '1DO9+T<= %\HOC9UC\ONA.R/CCW'1Y*LZ\[/
MP]-BLXV$JZ?'YW'3XW*X_/X/.X&OJZ+)4E'F]OY_$TM;2234]1")X%\D4B:D
M8VV+>K[EW=H=YVTJ+R!B5U"JFH*LK $$JRDJ:$&AP0<]%6][/9;_ +7-M&X
MFTG6C4-&%"&5E)! 96 (J"*C((QU27\:_P#A-1\/_C=WWU+W[C>X_D'O;-].
M[YP'8NV]N;ARVR,;@:S=.U*Z+,;:GR\VVMG8G,U%#C,Y2P53TT=3%'5>$0S:
MX'DC>3=Z]ZN8MZVFXVE[:SBBN8FC9E#E@KBC4U.14J2*T-*U%" 1&^S>SG+^
MS[I!NJ7%W)+;RK(JL4"EE-5KI0&@8 TJ*TH<$CJ\GY%=$;(^3W1?:GQ][';+
MQ;)[<V7F=E;@JMOUD6/SV.I<M3F.++82LJ:6NHX,OB*M8ZJF,]/44YFA430R
MQ%XVB[9MUNMCW2#=[+3]5;RAU#"JDCR85!H14&A!H<$'/4F;OM=MO6V3[5>:
MOIKB,HQ4T8 ^8-"*@Y%0149!&.M<;_H$\^&O_>1WR;_ZG=5__:^]S+_K^\R?
M\H=C_P!5?^MG40_ZQ7+O_*9>_P#5+_K7U[_H$\^&O_>1WR;_ .IW5?\ ]K[W
M[_7]YD_Y0['_ *J_];.O?ZQ7+O\ RF7O_5+_ *U]+KK#_A+C\,^M>R-A=B'O
M+Y';E;8>\-N;QAV_DLAUS18W,U.VLO29FEQN2JL7L2FR4./JZFB1)S3RPSF(
ML(Y(V(=4M][Z<R7ME+9_2V2>+&R:@)"0&!!(!D(J <5!%>(/#I39>R?+MG>1
M7?U-X_A2*^DF, Z2" 2$!H:9H0:<".MF?W"74S=4K_S$OY'/QL_F.=T8#O;L
MGLCN'KS>>'V%B^O*N'KZOVFV&S.)PF7S>7Q-;4T>Z-L9Z:DR=.^X*B%V@ECA
MEB6.\8=7>22^3_=#>N3=M?:K*&VFMFE,@\0/J!8*" 59:CM!R*@US3 CGFWV
MTV?F_<4W2\FN(;A8A&?#*T(4L02&5J'N(P:$4Q7)-5_+K_EU].?RU^G-R=/=
M/;DWYO"DWAORO["W+N7L*OP]7F*S,5>'PVWZ:CHZ;;^&P6)Q^*Q^)P4 1! \
MSS/*[RLK1QQ$/./..Y<Z;DFX[BD4;1Q"-5C!  !+$DL6))+'SI2@ XDGG*/*
M.W\G;>^W[>\LBR2F1FD())("T&D*  %'E6M23P /]["70JZ#[MKK/;'=/579
MG3F]DK9=F=L]?;SZSW=%C:D461DVQOS;F2VMGTH*QHIUI*U\5E91%*4<1R6;
M2;6]J]OO9]LOX-RM:?4V\R2)45&J-@RU'F*@5'22_LH=QL9MON:_3SQ/&]#0
MZ74JU#Y&A-#UKO=7?\)<_A=UIV;L+L<]V_)#=";"WEM[>=/MK*Y3KJBQV:J-
MM9:ES-#B\M78C8-'E$QM554<:5)I9*>H>$N(I87*R),-][Y\RWMC+9_2V4?B
MQLFH"0E=0() ,A%0#BH(KQ!&.HELO9/ERSO8KSZF\?PI%?23& =)! )" T)&
M:4-.!''K9B]PGU,O4+)8ZCR^.K\3D8?N,?E**JQU=3^26+ST=;!)35,/E@>*
M:+RP2LNI&5EO<$'GW9':-Q(AHZD$?:,CJKHLB&-\HP(/V'CUK!?] H_P>_CO
MWW^G;Y/?P+^+_=_P#^,=8^7^$_>>;^$?Q?\ T;^?7]G^S]SX]=_7IOQ[G'_7
M[YH\+1]+8^+IIJI+QIQIXGKFGY=0K_K&<M>+J^JO?"U5TUCX5X5\/TQ7\^MG
MW&XZCQ&.H,3CH?M\?BZ*EQU#3^267P4=%!'34T/EG>6:7Q01*NIV9FM<DGGW
M!SNTCF1S5V))^TY/4U(BQH(TPB@ ?8.'4WW7JW7O?NO=$H^9?\O+XE?/;;%%
MM_Y)=5XW=.3PE/-3[4W_ (BHGVWV1LZ.>1II(=O[QQ9BR*8V2H8RR8ZJ^ZQD
MTMGEIG95($W+?.','*<YFV6X:-&-7C/=&_\ ID.*^6H48# 8=!OF+E+8>:81
M%O$ =U':X[9$_P!*XS3STFJDY(/6N#VC_P ))=FUF3J*OI;YG[GV]AVF;[3
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+WOW7NO>_=>Z__]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
